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 Adenosine (Ado) is an endogenous neuromodulator which is widespread in the central 
nervous system.  It is a metabolite of ATP, hence its ubiquitous presence, yet this purine 
nucleoside has an importance that surpasses cellular energy maintenance.  It is a known 
modulator of synaptic transmission, and its global presence places it at center stage for many 
physiological processes.  Its ubiquitous presence is convoluted by different types of adenosine 
receptors which are coupled to diverse intracellular cascades and are expressed in a brain 
region-specific and cell-type specific fashion.  This diversity allows adenosine to serve many 
behavioral roles. 
 Adenosine is well understood in the hippocampus, where it influences the induction 
of synaptic plasticity.  Adenosine has been shown to decrease the magnitude of long-term 
potentiation (LTP), whereas blockade of specifically the A1 receptor (A1R) has been shown to 
facilitate the induction of LTP (reviewed by Costenla et al. 2010).  As adenosine acts at 
metabotropic receptors which initiate vast and divergent intracellular cascades, there are many 
mechanisms by which it may facilitate or inhibit plasticity induction.  The most obvious is the 
ability for A1R activation to selectively inhibit NMDA currents, which are necessary for many 
types of LTP (de Mendonҁa et al. 1995, Klishin et al. 1995).  A1R activation also decreases 
presynaptic release probability by inhibiting presynaptic Ca2+ influx (Gundlfinger et al. 2007, Wu 
and Saggau 1994, 1997) and reduces cell excitability through increased K+ conductance and 
membrane hyperpolarization (Trussel and Jackson 1985, 1987, Thompson et al. 1992, Takigawa 
and Alzheimer 1999, 2002).  This provides a straightforward hurdle in the induction of plasticity 
by limiting the efficacy of transmission.  In addition, all adenosine receptors’ intracellular 
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cascades converge upon adenylate cyclase and subsequently cyclic-AMP (cAMP) production 
which have been implicated in the mechanisms by which cells express plastic changes 
(elevations in cAMP have been linked to the initiation of long term enhancements in synaptic 
transmission; Weisskopf et al. 1994, Tzounopoulos et al. 1998).  Namely, activation of the A1R 
inhibits adenylate cyclase activity and decreases cAMP production whereas activation of A2A 
receptors does the opposite (Dunwiddie and Masino 2001). 
 Adenosine’s capacity to modulate dopaminergic transmission is well documented 
within the striatum. The activation of adenosine A2A receptors (A2ARs) on enkaphalin-positive 
medium spiny neurons directly inhibits the activity of co-localized dopamine (DA) D2 receptors 
through membrane receptor-receptor interactions (where it decreases the affinity of the D2 
receptor for dopamine) and through convergence on the intracellular cascade (where A2AR 
activation increases adenylate cyclase activity and D2 activation decreases it; Ferré et al. 20071).  
On substance-P positive medium spiny neurons, antagonistic interactions occur between A1Rs 
and D1 receptors.  A1R activation in these neurons changes the binding characteristics of the D1 
receptor to a lower affinity state (Ciruela et al. 2011). The consequence behaviorally is that 
locomotor and motivational behavioral models which are regulated by dopaminergic 
transmission are also modulated by adenosine.  A tonic activation of these adenosine receptors 
translates to a tonic suppression of dopamine transmission.  Antagonism of these adenosine 
receptors thus results in enhanced dopaminergic transmission, resulting in therapeutically 
beneficial behavioral effects such as increased motivation, locomotion, and reduced tremor (For 
review see Salamone et al. 2008, Nunes et al. 2010, Collins-Praino et al. 2011, Salamone et al. 
2012). 
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 In the cortex, adenosine levels rise dramatically in response to traumatic events such 
as hypoxia and ischemia.  Acute A1R activation reduces neuronal damage following these types 
of trauma (for review see Cunha 2005, Gomes et al. 2011).  Although the exact mechanism of 
neuroprotection by adenosine is not well elucidated, it appears to be a combination of 
adenosine’s capacity to powerfully suppress glutamatergic transmission as well as its position as 
a regulator of cellular metabolism.  Adenosine accumulation, reflective of cellular energy use, 
initiates cascades inside the cytoplasm which limit further cell energy expenditure and 
transmission analogous to a negative feedback loop (Chen et al. 2013).  Adenosine is also an 
endogenous anticonvulsant (Rho et al. 2013).  Excessive adenosine clearance has been linked to 
the etiology of epilepsy (Boison 2013).  Increasing adenosine levels and thus increasing the 
activation of A1Rs has been shown to suppress seizures (Masino et al. 2011, Rho et al. 2013). 
 Adenosine signalling has also been implicated in the control of sleep and waking states 
in several brain areas.  Thalamic neurons express two modes of firing.  During awake behavioral 
states (and more depolarized membrane potentials) these neurons transmit action potentials 
reliably (tonic firing mode).  Hyperpolarization of these neurons (corresponding to sleep states) 
causes them to engage in burst firing (bursting mode; Lu et al. 1992, Pape 1992, review by 
Bjorness and Greene 2009).  By increasing K+ conductance and hyperpolarizing neurons, as well 
as through the inhibition of other modulatory systems such as acetylcholine, adenosine aids in 
the transition of these neurons’ firing patterns to a state associated with sleep (Pape 1992, for 
review see Bjorness and Greene 2009).  There exist neurons within the basal forebrain, 
mesopontine tegmentum, and hypothalamus which are preferentially active during waking.  
Adenosine decreases release probability of neurotransmitters and decreases cell excitability in 
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these neurons many of which are part of the acetylcholinergic arousal system; Rainnie et al. 
1994, reviewed by Strecker et al. 2000, Arrigoni et al. 2006, Liu and Gao 2007).  Within the 
ventrolateral preoptic area and the preoptic/anterior hypothalamic area, there exist neurons 
which are active mainly during sleep.  A selective suppression of GABAergic transmission by 
adenosine in these areas mediates a disinhibition of these neurons (see Strecker et al. 2000, 
Moriarty et al. 2004.  Adenosine promotes sleep by inhibiting the acetylcholinergic arousal 
system and inhibiting wake-active neurons while simultaneously disinhibiting sleep-active 
neurons. 
 These examples illustrate a multitude of roles and effects of adenosine, while 
highlighting a significant diversity of action across the brain.  Whereas the roles of adenosine in 
the hippocampus, striatum, and in subcortical structures are well defined, the role of adenosine 
in regulation of neocortical functions is much less understood.  The neocortex is a critical brain 
area in the processing of sensory stimuli and higher order cognition.  It is responsible for 
numerous functions many of which have been demonstrated to be influenced by adenosine 
signaling.  
 It is known that adenosine levels fluctuate in the neocortex as a function of behavioral 
state and sleep need.  Generally, adenosine levels accumulate during waking and are highest 
after prolonged wake periods, and subsequently decrease during sleep, with lowest levels 
occurring at the end of sleep (discussed by Bjorness and Greene 2009).  Adenosine administered 
exogenously is sleep promoting, while antagonism of adenosine receptors (such as by caffeine) 
is known to increase vigilance and waking (Bjorness and Greene 2009).  It is also known that 
adenosine modulates sleep homeostasis and neocortical slow oscillations (Halassa et al. 2009).  
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Slow wave sleep (occurring during NREM sleep) is marked by slow cortical oscillations which are 
thought to be homeostatically regulated.  If an organism has an increased need for sleep, such 
as after sleep deprivation, it will respond during subsequent sleep with increased sleep time 
and increased length of NREM bouts.  Mice lacking adenosine tone do not demonstrate 
compensatory increases in these measures after sleep deprivation (Halassa et al. 2009). 
 Plasticity in the neocortex is thought to underlie permanent memory storage, an 
action necessary for long-term learning.  A role for adenosine here is suggestive yet tentative 
due to the well documented influence of adenosine on plasticity in the different architecture of 
the hippocampus. 
 Adenosine receptor activation in the cortex in general has been implicated in a 
neuroprotective role, mitigating damage after traumatic events.  As mentioned, epileptic 
seizures, which are cortical phenomena, have been demonstrated to be influenced in 
therapeutic ways by adenosine receptor activation (Boison 2013, Rho et al. 2013). 
 Adenosine’s ability to modulate glutamatergic and dopaminergic transmission within 
the frontal lobe has raised the possibility of therapeutic application in schizophrenia, where 
hypotheses propose glutamate hypofunction and dopamine hyperfunction play a role in 
etiology (Boison et al. 2012).  It is presumed adenosine may modulate forebrain dopaminergic 
transmission in a way that is etiologically relevant to schizophrenia. 
  Heterogeneous expression of adenosine receptors in different brain areas 
provide unique environments at which adenosine is able to act and modulate other 
neurotransmitters.  In each physiological role it serves, it is this profile of expression along with 
its specific neuroanatomical context that gives adenosine its relevance.  The nature of 
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adenosine’s modulation of synaptic transmission then, is very diverse.  This diversity demands 
explicit demonstrations in electrophysiology to provide a foundation on which adenosine’s 
actions in a given brain area can be understood.  While thorough electrophysiological work has 
been done in other brain areas, a comparable demonstration in the neocortex is lacking.  
Understanding roles of adenosine in normal operation of the neocortex and during dysfunction 
requires demonstration of adenosine effects on specific types of cells and connections.  
 The goal of the present work, then, is to uncover the synaptic actions of adenosine in 
the neocortex.  Here we sought to investigate adenosine’s effects on excitatory synaptic 
transmission in layer 2/3 of the rat visual cortex, and determine which receptors mediate these 
effects.  This knowledge informs us of the synaptic capabilities of neocortical adenosine and 
provides groundwork for a mechanistic basis for known behavioral and physiological roles of this 
neuromodulator. 
 To frame the present work, it is best to first consider the general principles of 
adenosine as a neuromodulator.  How it is synthesized and degraded, neuronal and glial sources, 
and what receptors for adenosine exist will all be considered.  A survey of various physiological 
roles in several brain areas will then serve to highlight the diversity of adenosine’s synaptic, 
neuroanatomical, and behavioral actions.  The focus will remain on the mechanistic bases of 
adenosine’s action and how they are utilized in different contexts.  The importance of an explicit 
profile of neocortical action (and the inability to generalize from heterogenous brain areas) will 
then be clear, and the rationale for the present work justified. 
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Formation and Degradation 
 There are two major pathways which result in adenosine formation inside of the cell.  
Adenosine triphosphate (ATP) is hydrolyzed to adenosine diphosphate (ADP), which is broken 
down into adenosine monophosphate (AMP), and finally adenosine.  Here endo-5’nucleotidase 
catalyzes the final reaction, which is also the rate limiting step. (Dunwiddie et al. 1997, Park and 
Gupta 2013, Sebastião et al. 2013).  In another pathway, S-adenosylhomocysteine hydrolase can 
catalyze a transmethylation reaction, converting S-adenosylhomocysteine into adenosine (and 
homocysteine).  Intracellular ATP concentration is about 100,000 times greater than adenosine 
concentration, meaning that relatively modest use of ATP by a cell results in significant increases 
in adenosine levels (Cunha 2005).  Extracellularly, membrane bound Ecto-5’nucleotidase (ecto-
5’ NT) can catalyze the formation of adenosine as endo-5’ nucleotidase does in the cytoplasm. 
This Ecto-5’NT is predominantly on glial cells (namely astrocytes), an importance which will be 
emphasized when considering the regulation of extracellular adenosine which is capable of 
acting on receptors.  As it is a metabolite of ATP, adenosine levels are linked to the energy use of 
a cell.  During synaptic transmission, there is an activity-dependent ATP release which, after 
conversion to adenosine, results in a suppression of transmission.  Therefore a modest energy 
use is coupled to a feedback mechanism which slightly conserves energy.  More dramatic events 
that deplete intracellular ATP initiate increases in adenosine, which initiate reciprocal feedback 
through many mechanisms.  Examples include increasing blood flow (through actions on 
endothelial A2ARs), increasing glucose availability (by increasing glucose transport, glucose 
delivery, and glycogenolysis), and by boosting metabolic processes which result in increased ATP 
(Chen et al. 2013).  In even more dramatic situations, in which traumatic events initiate 
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excitotoxicity and spur large increases in adenosine, adenosine receptor activation can help 
initiate astrogliosis and other reparative mechanisms.  This coupling to the energetic use of a 
cell has earned it the title of a ‘retaliatory metabolite’.   
 The degradation of adenosine can be accomplished by its conversion to inosine by 
cytoplasmic adenosine deaminase and ecto-adenosine deaminase.  Adenosine kinase (ADK) 
phosphorylates adenosine back into AMP, and is a major mechanism for the removal of 
adenosine.  It is prominent in astrocytes, which will reveal themselves to be important players in 
the production and removal of adenosine. 
 
Where does adenosine come from/when is it released? 
 The sources of adenosine are multiple, and the rules governing its release 
multifaceted.  Passive bi-directional nucleoside transporters do exist in neuronal membranes, 
yet experimental evidence indicates these typically serve to take up adenosine into the 
cytoplasm rather than release it into the extracellular space (Wall and Dale 2008, Cunha 2008).  
Being passive, the net flow of adenosine through these transporters depends on the relative 
concentrations on either side of the membrane.  Under specific circumstances, such as 
intracellular buildup due to excessive ATP use, cytoplasmic adenosine deaminase inhibition or 
deficiency, or excessive clearance in the extracellular space, these bi-directional transporters 
could serve to release adenosine directly.  Recently, adenosine release through nucleoside 
transporters has been demonstrated in hippocampal neurons during physiologically relevant 
spiking activity (Lovatt et al. 2012). 
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 Rather than being released as is, it appears much adenosine is formed within the 
extracellular space from ATP, which may be co-released with neurotransmitters or released from 
astrocytes.  The ATP is then broken down into adenosine by the processes outlined above.  The 
total time course for this conversion is about 200 milliseconds.  Again, the final conversion of 
AMP to adenosine is the rate limiting step (Dunwiddie et al. 1997).  While many enzymes 
catalyze the hydrolysis of ATP to ADP and ADP to AMP, only ecto 5 nucleotidase catalyzes the 
reaction that results in adenosine formation from AMP (Lovatt et al. 2012). 
 Indeed ATP can be released from nerve terminals in an activity dependent manner, 
particularly under high frequency firing, such as during stimulation protocols utilized for the 
induction of long-term potentiation (Wall and Dale 2008, Sperlagh and Vizi 1996, Cunha 2008).  
In this circumstance it would be broken down to adenosine by 5’-ectoNT and activate 
synaptically located receptors with high temporal and spatial specificity. 
 Recent research has confirmed the importance of astrocytes as a source of 
extracellular adenosine.  Astrocytes, though electrically passive, can serve to release 
gliotransmitters like ATP in an activity-dependent manner (Halassa et al. 2007).  Indeed 
astrocytes contain many neurotransmitter receptors and show responsiveness to glutamate.  
Activation of astrocytic receptors can cause Ca2+ influx which propagate (even to other gap-
junction coupled astrocytes) via ‘Ca2+ waves.’  These Ca2+ waves can stimulate the release of 
vesicularily stored gliotransmitters (Halassa et al. 2007).  Using transgenic mice in which SNARE-
dependent vesicular release from astrocytes was impaired, it was demonstrated that vesicular 
ATP release from astrocytes (and its subsequent metabolism to adenosine) was responsible for a 
tonic inhibition of transmission at Schaffer collateral synapses in hippocampal slices (Pascual et 
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al. 2005).  Antagonism of A1Rs in wild-type mice was able to mimic the transgenic mice, and A1 
agonism was able to reverse the effects of impaired vesicle release in the transgenic mice, 
indicating it was astrocyte-derived adenosine, rather than other gliotransmitters contributing to 
these effects.  Utilizing the same transgenic mice yet working in the neocortex, tonic inhibition 
of synaptic transmission by astrocytic-derived adenosine acting on the A1 receptor was found 
(Halassa et al. 2009).  Because the responsiveness of astrocytes is slower than neurons and their 
influence spatially broad, adenosine signaling sourced from these glial cells is postulated to be 
more broadband (that is low temporal and spatial resolution). 
 Whether from astrocytes or nerve terminals, the formation of extracellular adenosine 
is activity-dependent.  Activity-dependent release of adenosine has been demonstrated in the 
caudate putamen, nucleus accumbens, hippocampus and neocortex (motor and prefrontal; 
Pajski and Venton 2012).  The predominant source of adenosine release in the caudate-putamen 
and nucleus accumbens was glutamate receptor dependent.  While glutamate receptor 
blockade by CNQX and AP5 decreased activity dependent adenosine release in these areas it did 
not in the hippocampus and cortex.  In hippocampus and cortex, the major source of adenosine 
release was from the breakdown of nucleotides (presumably ATP, and quite possibly astrocytic 
in source).  This suggests differential sources for adenosine in different brain areas.  Notably, this 
group found the highest levels of activity-dependent adenosine release (and the most 
inconsistent detection by voltammetry) in the caudate-putamen and nucleus accumbens, areas 
associated with glutamate receptor dependent release.  Lower levels of release (which were 
more reliably detected) were found in the hippocampus and cortex, areas associated with ATP-
derived adenosine (Pajski and Venton 2012).  In theory the source of adenosine in the 
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hippocampus and cortex is from a broadband and reliable (albeit more modest) breakdown of 
ATP.  Astrocytes are good candidates for this source as they have been suggested to fulfill the 
role of providing temporally and spatially general rises in adenosine.  In contrast, caudate-
putamen and nucleus accumbens appear to have more extreme though less reliable rises in 
adenosine, possibly sourced synaptically and locally after ionotropic glutamate receptor 
activation.  A less diffuse source of adenosine may underlie the less reliable detection. 
  
Receptors: their intracellular cascade and distribution 
 There are four recognized metabotropic adenosine receptors coupled to different g-
proteins: the A1 (Gi/o linked), A2A (Gs/olf linked), A2B (Gs linked), and A3 (Gi/q linked).  A1 and A3 
receptors inhibit adenylate cyclase and decrease cyclic-AMP (cAMP) production, while A2A and 
A2B activate adenylate cyclase and increase cAMP production (Dunwiddie and Masino 2001).  
This action on cAMP subsequently results in the modification of Protein Kinase A (PKA) activity.  
The importance of adenosine’s actions on the intracellular cascade is further discussed as it 
becomes relevant to different physiological roles adenosine serves. 
 The A1R is expressed in high concentrations all throughout the brain, notably in 
cerebral cortex. A2ARs are most dense in the striatum and olfactory bulb.  A2A, A2B and A3 
receptors were also found throughout the brain at lower levels (Dixon et al. 1996, Fredholm et 
al. 20011). A3 receptors have been reported in the hippocampus and neocortex specifically 
(Lopes et al. 20031,2; Brand et al. 2001).  The highest density of A3 receptor protein mRNA has 
been reported in the hippocampus and cerebellum (Brand et al. 2001).  Though some work 
revealing functional A3 receptors has been published, limited work has covered A2B receptors 
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and their role in brain physiology.  Being the most densely expressed and bearing the most 
explicit effects on brain physiology, the A1Rs and A2ARs have been the focus of most adenosine 
receptor research, and are the focus of the present work as well.   
 It is important to note that while typically the receptors outlined couple to their 
respective G-proteins, an enormous diversity of exceptions exists.  Depending on brain 
structure, cellular location, and even sub-cellular location, a given adenosine receptor can 
couple to a range of G-proteins and transduction mechanisms (Cunha 2005).  One of the well-
studied examples is the heteromerization of receptors, specifically within the striatum.  As 
clarified by Ferré (Ferré et al. 20072): “A receptor heteromer can be defined as a complex 
molecule made up of different receptor molecules for the same or different neurotransmitters.”  
In essence, it is a protein complex comprised of two or more neurotransmitter receptors.  
Homomers (in which the complex is comprised of two or more of the same receptor) also exist.  
Whereas coupling to the Gs protein is typical for A2ARs, it was found that when CB1 receptors 
are present (and forming heteromers with A2ARs), the A2AR couples to the Gi protein instead 
(Orrú et al. Neuroscience 2012 abstract).  Heteromerization has consequences for the binding 
and subsequent action of ligands as well.  Research has shown distinct populations of A2ARs 
within the striatum.  Specifically, presynaptic A2ARs coupled to A1Rs and A2ARs which do not 
heteromerize formulate one population, while postsynaptic A2ARs heteromerizing with 
dopamine D2 receptors (D2Rs) seem to comprise a different population.  The two populations 
are pharmacologically separable through the use of A2AR ligands, which demonstrate different 
effects in in vivo models and also different binding characteristics in in vitro preparations (Orrú 
et al. 20111).  Extending these principles, there has been shown heterogenous binding 
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properties of supposedly selective A2AR ligands when comparing the striatum and the cortex 
(Lopes et al. 2004).  Pharmacological and binding studies using the A2A agonist CGS 21680 show 
clear binding in striatum, but an unidentified atypical binding site in the cortex.  The binding of 
this ligand in cortex appears to require the presence of the A1R, suggesting possible heteromeric 
complexes with unique binding properties. (Lopes et al. 2004)  This heterogeneity of receptor 
distribution, cellular location, and transduction is a recurring theme in the diversity of 
adenosine’s actions, and as such will reappear often. 
 
Receptors: cellular/synaptic location and effects on other transmitters 
 Adenosine’s noted electrophysiological actions come from action at pre, post, and 
extrasynaptic receptors.  In general, presynaptic receptor activation modulates release 
probability through action on Ca2+ influx, and also by interfering downstream with release 
machinery.  Receptor activation also has various effects on membrane properties and 
excitability of the neuron, including influencing Ca2+ and K+ conductance and altering the 
functioning of postsynaptic receptors for other ligands. 
 
 A1Rs 
 Adenosine acting on presynaptic A1Rs reduces the release probability at a synapse by 
inhibiting calcium influx at the presynaptic terminal through N-type and P/Q-type Ca2+ channels 
(Gundlfinger et al. 2007, Wu and Saggau 1994, 1997).  There is also evidence that adenosine is 
acting downstream of Ca2+ influx to reduce the efficacy of the exocytotic machinery (Gomes et 
al. 2011, Scanziani et al. 1992, Scholz and Miller 1992).  A1Rs have been demonstrated to inhibit 
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the release of glutamate, aspartate, acetylcholine and serotonin (Lupica et al 1992, Silinsky 
1984, Corradetti et al. 1984, Cunha 2005, Fontantez and Porter 2006).  They have been 
discussed as preferentially inhibiting excitatory transmission.  In some preparations within the 
neocortex however, GABAergic transmission is suppressed by adenosine (Kirmse et al 2008, 
Zhang et al. Neuroscience 2012 abstract).   
 Postsynaptic/nonsynaptic receptors also exist.  Postsynaptic A1Rs have been linked to 
the activation of G-protein coupled inwardly-rectifying potassium channels (GIRKs), which 
increase potassium conductance (Trussel and Jackson 1985, 1987, Thompson et al. 1992, 
Takigawa and Alzheimer 1999, 2002).  The major effect of this activation is the hyperpolarization 
of the membrane, effectively decreasing the excitability of the neuron, and consequentially the 
impact of excitatory transmission on the postsynaptic membrane.  In hippocampal pyramidal 
cells, there is a tonic activation of GIRKs by adenosine acting on A1Rs (Takigawa and Alzheimer 
2002).  Hyperpolarization by GIRKs not only shunts excitatory post-synaptic potentials (EPSPs) in 
the direct manner, but also limits the conductance of voltage dependent channels (notably Ca2+ 
channels; Takigawa and Alzheimer 2002). 
 A2ARs 
 The A2AR functions in a manner nearly opposite to the A1R.  Presynaptic A2AR 
activation facilitates glutamate, GABA, serotonin, noradrenalin and glycine release (Marchi et al. 
2002, Cunha 2005).  A2AR activation increases acetylcholine (ACh) release in cerebral cortex, 
hippocampus, striatum, and motor nerve terminals.  Within the hippocampus, heterogeneity 
exists in the ability of adenosine to modulate ACh release.  In CA3, A1Rs and A2ARs are present 
and modulate ACh release.  In CA1, however, only A1Rs seem to modulate release of ACh 
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(Sebastião and Ribeiro 1996).  GABA release is enhanced by A2AR activation in hippocampus, yet 
in striatum, GABA release is inhibited by A2AR activation (summarized by Marchi et al. 2002).  
A2ARs in striatum are present on corticothalamic to medium spiny neuron (MSN) contacts, as 
well as symmetric MSN contacts where they are mainly postsynaptic. Elsewhere in the brain 
(specifically cerebral cortex) they typically take a presynaptic locus and control transmitter 
release (Rebola et al. 20051,2 ,  Chen et al. 2013) In addition to its direct actions, A2ARs can affect 
transmission indirectly through receptor interactions with the A1R.  A2AR activation can shunt 
the effects of the A1R causing an indirect excitation dependent on tonic A1R activation (Phillis 
2001, Lopes et al. 1999, Lopes et al. 2002).  On presynaptic gluamatergic terminals in the 
striatum, A1R-A2AR heteromers exist in which activation of the A2AR decreases the affinity of the 
A1R for its ligand. 
 A2AR activation alters membrane properties of neurons as well, although the literature 
is less exhaustive for description of these actions.  In hippocampal pyramidal neurons, A2AR 
agonism was shown to depolarize neurons and increase their input resistance, in direct contrast 
to A1R activation (Li and Henry 1998).  In the supraoptic nucleus, A2AR activation can modify 
membrane excitability and increase firing activity by depolarizing neurons (Ponzio et al. 2006).  
The mechanism by which this occurs appeared to be Na+ channel dependent (and possibly 
involving metabotropic glutamate receptors).  At the mossy fiber synapse, A2AR activation 
selectively potentiates NMDAR-mediated EPSCs without effect on AMPAR-mediated EPSCs 
(Rebola et al. 2008).  This supports a postsynaptic locus of action whereby A2ARs facilitate 
transmission and increase excitability. 
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 A3Rs 
 A3 receptor (A3R) mRNA has been found using techniques that dissect single pyramidal 
neurons of the hippocampus (Lopes et al. 20032).  A3Rs are found to be lower affinity as well as 
much more sparsely expressed, leading researchers to presume that they are active only under 
special physiological circumstances, such as during traumatic events which result in the 
accumulation of extremely high adenosine concentrations (Lopes et al. 20032).  Recordings from 
layer 5 pyramidal neurons within the associative frontal cortex (with stimulation in layer 1) 
demonstrated that the A3 agonist IB-MECA decreased the amplitude of postsynaptic potentials, 
probably through a reduction in glutamate release.  IB-MECA had no influence on membrane 
properties such as resting potential or input resistance (Brand et al. 2001).  In this study, neither 
A1R nor A3R agonism displayed measurable effects on membrane properties. 
 
Roles of Adenosine 
 Adenosine has been implicated in many physiological roles.  Despite the ubiquity of 
adenosine in the CNS, it is the source of this modulator and profile of receptor expression that 
truly determines the actions of adenosine.  Adenosine’s actions in different brain areas 
demonstrate significant heterogeneity on the behavioral and physiological level owing to this 
diversity.  The relevance of both adenosine source and receptor expression is expounded more 
appropriately in context, namely through discussion of the physiological roles served by 
adenosine. Several roles will be considered, with special attention to the synaptic and 
anatomical features that make these actions possible. 
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Plasticity regulator: insight from the hippocampus 
 The modulation of a synapse during the induction of plasticity can affect the 
induction’s outcome, and thus exert influence on a long lasting timescale.  In fact, adenosine 
receptor ligands have been demonstrated experimentally to affect synaptic plasticity (de 
Mendonҫa and Ribeiro 2001, Costenla et al. 2010 for review).  Generally A1R agonists inhibit 
long-term potentiation (LTP) while A2AR agonists facilitate LTP.  Adenosine receptors have 
several potential mechanisms by which they might influence the induction of synaptic plasticity.  
One mechanism of action for adenosine ligands on the induction of plasticity could be related to 
glutamatergic NMDA receptors (NMDARs).  Ca2+ influx resulting from NMDAR activation is 
implicated as a critical step in the induction of many types of LTP.  A1R activation is able to 
inhibit NMDAR responses.  The adenosine analog 2-Chloroadenosine, by acting on A1Rs, was 
demonstrated to reversibly inhibit NMDA currents (de Mendonҫa et al. 1995).  Conversely, in 
the hippocampus it was found that A1R blockade by DPCPX preferentially increased the NMDA 
component of EPSCs (Klishin et al. 1995).  A1R regulation of NMDA receptors (NMDARs) has 
been demonstrated more recently in the cortex (Deng et al. 2011).    Mice with impaired 
astrocytic vesicle release (dnSNARE mice), which subsequently show a lack of A1R activation, 
demonstrated reduced NMDAR function while AMPA currents remained unaffected.  This 
attenuation of NMDAR functioning was linked to a reduction in surface expression of NR2A and 
B NMDA receptor subunits due to reduced Src Family Kinase activity.  Activation of A1Rs in 
dnSNARE mice mimicked the wildtype phenotype, increasing NR2B subunit expression and 
NMDAR function.  Conversely, A1R antagonism in wildtype mice showed the same phenotype as 
the dnSNAREs.  A1Rs, activated by endogenous adenosine can regulate NMDARs in pyramidal 
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neurons (Deng et al. 2011).  This selective inhibition of NMDAR function could make the 
induction of plasticity more difficult. 
 NMDARs are not the only possible locus for adenosine’s control of plasticity, however. 
An NMDA-independent LTP mediated by A2Rs at the mossy fiber synapse has been described 
(Kessey and Mogul 1997).  This was presumably due to postsynaptic A2AR activation during 
induction and subsequent increase in AMPA receptor function or expression.  The authors of 
this study also highlight the possible importance of cAMP levels after an induction in 
determining the outcome of a protocol.  Adenosine receptor activation can manipulate cAMP 
levels through their actions on adenylate cyclase, offering another avenue by which 
potentiation may be influenced by adenosine.  Weisskopf et al. 1994 suggest cAMP elevations 
contribute to long lasting potentiation of glutamatergic transmission at these synapses.  
According to Tzounopoulos et al. 1998, adenlyate cyclase activation and subsequent increase in 
cAMP levels and activation of the protein kinase A pathway would initiate a long-term 
potentiation.  A2A receptor activation is known to increase cAMP, and thus may contribute to an 
intracellular cascade known to affect plasticity.  In addition, Blockade of A1Rs may increase 
adenylate cyclase activity and increase cAMP through the removal of tonic A1R activation.   
Conversely, reduction in cAMP levels at the mossy fiber synapse (feasible through the blockade 
of A2ARs and/or activation of A1Rs) may attenuate plasticity. 
  There exist additional avenues for adenosine receptor ligands to influence plasticity at 
a synapse.  Postsynaptic A1R activation has also been linked to actions which hyperpolarize cells, 
decrease their input resistance, and reduce excitability of the cells.  There is a well documented 
K+ conductance mediated by GIRKs which is activated by A1Rs.  In addition, the inhibition of Ca
2+ 
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currents by A1R activation provides an obvious hurdle to plasticity induction.  Adenosine has 
also been noted to preferentially inhibit excitatory transmission in hippocampal cell cultures 
(Yoon and Rothman 1991).  A diminished impact of EPSPs with normal GABAergic transmission 
could bias a synapse towards quiescence, providing a more difficult environment in which to 
induce plastic changes.  Lastly, while adenosine receptor ligands certainly operate to regulate 
plasticity in manners independent of changes to basal transmission, this does not remove 
adenosine’s ability to reduce glutamate release and inhibit EPSPs as an important factor.  Of 
course, an inhibition of release will create a hurdle for the induction of long lasting synaptic 
changes. 
 A phenomenological assessment of the impact of different adenosine receptor ligands 
on the outcome of plasticity-inducing protocols within the hippocampus serves to link these 
known mechanisms of action to physiological relevance.  The vast majority of work regarding 
synaptic plasticity and adenosine (and all referenced here unless otherwise stated) has been 
done in hippocampal slices (typically CA1).  Ground-breaking work found an inhibition of LTP by 
2-Chrloroadenosine and related it to reduced Ca2+ influx (Dolphin 1983).    Both adenosine and 
2-Chloroadenosine were shown to decrease the magnitude of high-frequency stimulation 
induced LTP as measured by population spike amplitude and field EPSP (fEPSP; de Mendonҁa 
and Ribeiro 1990, 1994).  Using the adenosine uptake blocker NB-I, they also found this 
inhibitory effect on LTP, implicating endogenous adenosine in the mediation of plasticity.  In 
contrast, blockade of A1Rs by DPCPX increased LTP induced by this high frequency stimulation.  
A1R blockade by DPCPX also increased the magnitude of LTP induced by theta burst stimulation, 
as measured by fEPSPs (Arai and Lynch 1993).  It did not alter, however, the upper limit of 
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potentiating magnitude.  This suggests A1R blockade may increase the ability of weak or near-
threshold protocols to induce LTP.  This is corroborated by the observation that weak 
stimulation becomes more likely to induce LTP with DPCPX in the background (Forghani and 
Krnjević 1995).  Previously subliminal trains can induce LTP on the background of DPCPX 
(reviewed by Costenla et al. 2010).  Thus, LTP induction is facilitated by A1R blockade, and under 
baseline conditions adenosine acting on A1Rs is exerting a tonic inhibition of LTP induction.   
The observation that LTP is attenuated by A1R activation and facilitated by its blockade is 
compatible with the knowledge that A1R activation inhibits NMDA currents and cAMP 
production, and that their blockade enhances both NMDA currents and cAMP production.  As 
NMDAR activation and increased cAMP have been linked to sustained increases in synaptic 
efficacy, their manipulation by A1Rs provide a reasonable mechanism by which adenosine 
modulates LTP. 
 Long-term depression (LTD) is also influenced by actions on adenosine receptors.  
DPCPX can increase the magnitude of homosynaptic LTD, indicating that endogenous adenosine 
acting on A1Rs inhibits both LTP and LTD (de Mendonҫa et al. 1997).  As with LTP, it appears A1R 
blockade lowers the requirements for induction of LTD.  At the Schaffer collateral-commissural 
pathway adenosine’s actions on homosynaptic LTD were tested.  A low-frequency stimulation 
that could not produce lasting LTD on its own was able to induce LTD on the background of 
DPCPX or after the removal of tonic A1R activation using adenosine deaminase (Kemp and 
Bashir 1997). 
 In contrast to homosynaptic LTD, heterosynaptic depression appears to be attenuated 
by a blockade/absence of A1R activation.  It was found that heterosynaptic depression induced 
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by theta-burst stimulation was absent in mice with impaired A1R activation (Using the previously 
mentioned dnSNARE mice; Pascual et al. 2005).  Similarly, DPCPX applied to a wildtype slice 
prevented the expression of heterosynaptic depression (Pascual et al. 2005).  Corroborating this 
notion, more recent work found DPCPX prevented HFS-induced heterosynaptic depression 
(Lovatt et al. 2012).  At least in the hippocampus, adenosine acting at A1Rs is critical in inducing 
heterosynaptic depression. 
 A2A receptors also mediate the induction of plasticity.  Generally they operate 
inversely to the A1R; A2AR antagonists attenuate LTP whereas agonists facilitate it.  Indeed, A2AR 
antagonism by SCH 58261 decreased LTP in the hippocampus (Costenla et al. 2011) while A2AR 
agonism via CGS 21680 facilitated potentiation (reviewed by Costenla et al. 2010).  In addition, 
the non-selective antagonist caffeine appears to attenuate LTP as would an A2AR antagonist 
(again reviewed by Costenla et al. 2010). 
 Concerns about effects of adenosine receptor ligands on basal transmission have been 
addressed by the above experiments in a few ways.  Notably, LTP induced at one level of release 
probability occluded that induced at a different (lower or higher) level (Asztely et al. 1994).  In 
most experiments, baseline responses were calibrated post ligand application to comparable 
levels with control slices.  In addition, the use of antagonists mitigates the effects of changes in 
basal transmission as they typically have minimal effects on these measures (de Mendonҁa and 
Ribeiro 2001).  
 The heterogeneity of receptor expression again precludes the extrapolation of 
mechanism in one brain area to another.  For example, adenosine’s ability to influence NMDARs 
is significant at Schaffer collateral synapses, but is irrelevant at the mossy fiber synapse.  In 
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addition to the variety of induction requirements possible at differing synapses is the role that 
adenosine source and receptor profile may play at a slightly broader level of analysis.  The 
localization of receptors provides the theater in which transmission is permitted to act.  Rodrigo 
Cunha and colleagues (Cunha 2008, Costenla 2010) describe an elegantly coordinated series of 
events in which broadband, slow transmission due to widely expressed A1Rs under tonic 
activation operates in conjunction with focal activation of A2ARs sourcing adenosine which is 
released in an activity dependent manner during high frequency stimulation (such as would 
occur at a homosynaptic site during an LTP induction).  In this situation basal or moderate levels 
of neural and astrocytic activity set an inhibitory tone mediated by a temporally and spatially 
broad inhibition of transmission through the A1R.  Conditions such as an induction protocol then 
cause a focal increase in adenosine at the active synapse, which reach levels sufficient to 
activate synaptic A2ARs which overcome A1R activation to facilitate transmission.  
Mechanistically, the activation of the A2AR has been demonstrated to reduce the affinity of A1Rs 
for their ligands in cortical synaptosomes (Lopes et al. 1999).  This would result in a selective 
facilitation of transmission at the homosynaptic site and a more diffuse A1R mediated inhibition 
at surrounding synapses.  The consequences for plasticity induction could be facilitation of LTP 
(through A2AR activation) at the active synapse and depression (through the A1R) at 
heterosynaptic locations.  In circumstances below the threshold this profile of adenosine may 
serve still to increase salience at an active synapse.  This circumstance is only possible due to 
the unique combination of receptor expression (ubiquitous A1Rs and synaptically restricted 
A2ARs) and multiple sources of adenosine. 
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 The striking difference between the relatively organized layout of pyramidal neurons 
in the hippocampus and the more dispersed presentation of pyramidal soma in the neocortex 
raises the question of generalizability.  Whether this situation is relevant to the neocortex, or if 
other organizational principles enact similar outcomes remains undetermined.  Exhaustive 
electrophysiological investigations in the hippocampus stand in contrast to the near-absence of 
investigation into adenosine in neocortical plasticity.  If the spatial profile of receptor 
localization is critical to potentiation and depression, the role of adenosine in neocortical 
plasticity cannot be assumed from other areas.  At the most basic level, knowledge of the pre 
and postsynaptic actions of adenosine precede any speculation of a role for adenosine within 
the neocortex, and would inform us of the parameters by which adenosine would be permitted 
to act. 
 
Adenosine and dopamine interact within the striatum: 
 Within the striatum, adenosine receptor activation is able to influence dopaminergic 
transmission through receptor heteromerization, intracellular convergence, and interactions on 
the neuroanatomical/circuit level.  Of specific concern here are the first two, as they highlight 
unique mechanistic actions of adenosine at the cellular level.  As mentioned above, the 
expression of A2ARs in the brain is most dense in the striatum (Dixon et al. 1996, Fredholm et al. 
20011).  Here, A2A and D2 receptors are colocalized postsynaptically on enkephalin positive 
GABAergic medium spiny neurons where they can interact through receptor heteromerization 
and convergence on the intracellular cascade (Ferré et al. 20071, Salamone et al. 2008, 
Armentero et al. 2011,).  A1 and D1 receptors also show a coexpression and heteromerization 
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within the striatum, yet on a distinctly separate population of substance-P positive neurons 
(Ferré et al. 20071, Ciruela et al. 2011).  In addition, adenosine A1R and A2ARs have been shown 
to colocalize and heteromerize on presynaptic glutamatergic terminals in the striatum 
(Reviewed by Ferré et al. 20071, 2, Ciruela et al. 2011). 
 The consequence of heteromerization is the most direct interaction possible.  In the 
case of postsynaptic A2A-D2 heteromers, activation of the A2AR decreases the affinity of ligands 
for the D2 receptor.  Blockade of A2ARs removes a tonic inhibition by adenosine, increasing DA 
receptor affinity and consequentially facilitating dopaminergic transmission (Ferré et al. 20071, 2, 
Ciruela et al. 2011).  In A1-D1 heteromers, adenosine receptor activation again decreases the 
affinity of the DA receptor for its ligand, and may also cause uncoupling of the D1 receptor from 
the Gs protein (Ferré et al. 20071, Ciruela et al. 2011).  In these scenarios the influence is 
unidirectional from the adenosine receptor to the dopamine receptor.  Although it is not 
directly modulating dopamine transmission, it is suitable to mention a third adenosine receptor 
heteromer present in the striatum.  Within presynaptic A1-A2A heteromers, activation of the 
A2AR ‘switches off’ A1Rs by decreasing their affinity (Ciruela et al. 2006).  Under normal 
circumstances and lower concentrations of extracellular adenosine, the inhibitory A1R is 
tonically activated.  As adenosine levels increase, the excitatory A2AR becomes activated and A1R 
mediated actions are shunted.  At a glutamatergic synapse, the consequence is an inhibition of 
glutamate release at lower concentrations of adenosine, and a local facilitation of transmission 
as adenosine levels rise high enough to activate A2ARs.  In addition to membrane interactions, 
adenosine and dopamine receptors both converge onto cAMP and PKA Pathways (discussed in 
Ferré et al. 20071).  Whereas A2AR activation stimulates adenlyate cyclase activity and increases 
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cAMP production, colocalized D2 receptors inhibit adenylate cyclase activity and decrease 
production of cAMP.  Conversely, A1R activation inhibits cAMP production by decreasing 
adenylate cyclase activity while colocalized D1 receptors increase cAMP production by 
increasing adenylate cyclase activity.  Here the integration of signaling from two different 
transmitter/modulatory systems is accomplished by converging upon adenylate cyclase in a 
mutually antagonistic way.  Because of the implication of impaired dopamine transmission in 
Parkinson’s disease and parkinsonism, and the linkage of dopamine receptors to adenosine 
receptors, adenosine receptors have been investigated as a potential therapeutic target. 
 
 Locomotion 
 Animal models of parkinsonism typically utilize drugs which decrease extracellular DA 
levels or block DA receptors to induce motor deficits such as rigidity, catalepsy, tremor, and 
reduced locomotor activity.  This is commonly achieved with DA antagonists such as haloperidol, 
DA-depleting agents such as reserpine and tetrabenazine, or by eliminating dopaminergic nerve 
terminals such as with the toxic 6-OHDA. 
 A2AR antagonists are effective in reversing the motor deficits present in these animal 
models.  Rigidity, catalepsy, hypolocomotion and impaired locomotion induced by DA-depleting 
agents or DA antagonism were reversed by various A2AR antagonists (such as MSX-3, SCH 58261, 
KW-6002, and KF17837; reviewed by Salamone et al. 2008).  Bilateral infusions of the reversing 
agent (MSX-3) directly into the nucleus accumbens shell, core, and the ventrolateral striatum 
(VLS) have highlighted the nucleus accumbens (specifically the core) as the locus for these 
locomotor manipulations (again reviewed in Salamone et al. 2008).  Antagonism of the A2AR 
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alleviates a tonic suppression of D2 receptor functioning, effectively increasing the efficacy of 
the limited dopamine available. 
 
 Tremor 
 Parkinsonian tremor has also been modeled.  The tremulous jaw movement (TJM) 
model typically employs striatal DA depletions or DA receptor antagonism to induce rapid 
deflections of a rat’s lower jaw.  This movement is not directed at any stimulus and occurs in a 
range typical of resting tremor in parkinsonian patients (3-7 Hz).  It is induced by the same 
manipulations that cause parkinsonism in humans (for example typical antipsychotics, 6-OHDA, 
reserpine, muscarinic receptor agonism, and anticholinesterases), and is relieved by 
interventions known to be antiparkinsonian (all reviewed by Collins-Praino et al. 2011). 
 Adenosine A2A receptor antagonism has been effective in reducing TJMs.  TJMs 
induced by typical antipsychotics (DA antagonists) such as haloperidol and pimozide were 
reversed by A2A antagonism. MSX-3 injected directly into the VLS was effective in suppressing 
pimozide induced TJMs (again reviewed by Collins-Praino et al. 2011).  For tremor, the locus of 
these pharmacological manipulations is the ventrolateral striatum.   
 
 Motivation 
 As noted in Salamone et al. 2012, animals in a natural environment are confronted 
with multiple avenues to obtain stimuli.  Which behavior the animal engages in is influenced by 
the amount of effort, or cost, involved, and the ‘reinforcement value’ of the stimulus.  The 
investigation of effort-related choice experimentally involves manipulating the cost/benefit ratio 
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of different options.  This can be modeled with different food choices attached to different work 
requirements.  In these paradigms, DA receptor antagonism or DA depletion within the nucleus 
accumbens shifts behavior away from the high cost/reward option and toward the low cost/low 
reward choice. 
 In a concurrent FR-5/chow procedure, a rat is given the choice between unrestricted 
access to laboratory chow, and pressing a lever to obtain a more palatable food pellet (a higher 
work requirement).  A normal rat will mostly press the lever for a more preferred food.  DA 
antagonists cause rats to press the lever less and reciprocally increase the free chow 
consumption.  Effectively, a rat with diminished DA receptor activation would choose the easier 
task despite the food being less preferable.  This is not demonstrably due to decreased appetite 
or motoric deficits (Nunes et al. 2010, Salamone et al 2012).  As with their ability to reverse 
parkinsonian locomotor deficits and TJMs, A2AR antagonists such as MSX-3 or KW-6002 
administered after DA antagonism have been shown to reverse the shift in effort-related choice 
back towards a higher work output (Nunes et al. 2010). 
 Both D1 and D2 antagonism (via ecopipam and eticlopride, respectively), shifted 
behavior away from lever pressing and increased consumption of lab chow (Nunes et al. 2010).  
A2AR antagonist KW-6002 was able to shift lever pressing and chow consumption back toward 
baseline after either ecopipam or eticlopride, though the A2AR antagonist was much more 
effective at reversing D2 antagonism.  Notably, neither DPCPX nor CPT (both A1R antagonists) 
was able to reverse the effort related choice shift induced by ecopipam (D1 antagonist) or 
eticlopride (D2 antagonist).  
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 The inability of A1 antagonism to reverse D1 antagonism, despite several known 
interactions between receptors (including heteromerization and intracellular cascade 
convergence) could be attributable to the overwhelming abundance of A1Rs throughout the 
striatum and rest of the brain.  The majority of these receptors would not necessarily be directly 
linked with D1Rs and thus numerous other effects of A1R blockade may occlude or overwhelm 
potential effects on DA transmission (Nunes et al. 2010). 
 Adenosine’s role in the striatum is particularly insightful because it exemplifies the 
exclusivity of certain mechanisms within a brain area.  Again, the expression of dopamine and 
adenosine receptors postsynaptically on medium-spiny neurons is a unique feature of the 
striatum by which adenosine signaling is integrated with dopaminergic transmission to tune 
behavior in a relevant manner.  This ability of adenosine receptors to couple in an antagonistic 
way with dopamine receptors and integrate signaling on the membrane and in the intracellular 
cascade is an exception, not a ‘rule.’  As noted, A2ARs elsewhere are often presynaptically 
located, and much sparser.  In these presynaptic scenarios they serve restricted roles, activated 
only during specific circumstances (such as facilitating transmitter release locally at a synapse; 
Marchi et al. 2002, Ciruela et al. 2006, Cunha et al 2008). 
 
Neuroprotection 
 As adenosine levels tend to rise dramatically following hypoxic and ischemic insults, 
and given its known suppressant actions on excitatory transmission, it has been thought that it 
acts as an endogenous neuroprotector (reviewed in Gomes et al. 2011,).  A wealth of culture, in 
vitro and in vivo experiments have followed and uncovered evidence that adenosine receptor 
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ligands do indeed incur neuroprotective benefits.  The homeostatic role of adenosine found in 
eukaryotic cells in general will not be considered here, though significant actions of adenosine 
in peripheral tissues and within the brain in endothelial cells play a role in neuroprotective 
action, vasculature control, and permeability of the blood brain barrier (Reviewed by Gomes et 
al. 2011). 
 In vitro, hypoxic/ischemic conditions can be created through oxygen deprivation and 
hypoglycemia. Typically damage is assessed by infarcted area/neuronal cell loss.  In both 
primary cortical and hippocampal cultures, ligands acting acutely on A1Rs mitigated neuronal 
damage (reviewed by Cunha 2005).  In direct contrast, antagonism of this receptor exacerbated 
morphologically assessed damage (reviewed by de Mendonҫa et al. 2000).  In vivo, acute CPA 
(A1R agonist) administration was able to decrease neural loss and mortality in gerbils following 
insult.  A1R agonists have also been found to prevent the damage associated with NMDA 
excitotoxicity (discussed by de Mendonҫa et al. 2000).  The mechanisms by which A1R activation 
acts to accomplish neuroprotection are not well elucidated, but likely center around its ability to 
inhibit Ca2+ influx, NMDAR function, and glutamate release. 
 While acute administration of A1R agonists is neuroprotective, chronic administration 
exacerbates damage (discussed by de Mendonҫa et al. 2000).  This inversion of protective 
benefit has been observed with antagonists as well.  Whereas the nonselective adenosine 
antagonist caffeine (or the selective A1R antagonist CPX) has been shown to exacerbate 
ischemic damage acutely, it confers protection at low chronic doses (Jacobsen et al. 1996).  
Chronic noxious conditions which cause sustained elevations of adenosine in the brain result in 
a down regulation of the A1R (Rebola et al. 20053).    The result is a decreased ability of A1R 
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activation to be neuroprotective (Sweeney 1997, reviewed by Cunha 2005).  The therapeautic 
window for adenosine acting on A1Rs also appears to be acutely after (within 15 minutes) the 
traumatic event (Sweeney 1997).  In this manner A1R activation is not a sustainable therapy in 
the long term but only acutely.  Considering traumatic brain events are difficult to predict and 
the acute administration of a drug during a seizure or stroke is not very realistic, the use of A1R 
agonists therapeutically faces major challenges.   
 While the protective role of A1R agonists is perhaps intuitive, A2A antagonists have 
received attention for their neuroprotective actions as well.  A2AR blockade is in fact 
neuroprotective in response to ischaemic or hypoxic insult, particularily in cortex. (reviewed by 
Cunha 2005).  In the rat, A2AR antagonist SCH 58261 reduced brain injury when administered 10 
minutes after focal ischaemia (Monopoli et al. 1998).  A2A knockout mice also demonstrated 
attenuated damage due to ischemia (Chen et al 1999).  The potential mechanisms conferring 
this protection are several, yet it is an area that remains poorly defined.  It is possible that 
blockade of endogenous adenosine acting on A2ARs influences the intracellular cascades which 
control apoptosis.  Blockade may also control inflammation (As supported by the observation 
that A2AR blockade mitigates inflammation triggered by lipopolysaccharide in the hippocampus; 
Rebola et al. 2011), astrogliosis following trauma, and perhaps through known actions on 
glutamate release/clearance (reviewed by Cunha 2005, Gomes et al. 2011).  A2A Receptors don’t 
desensitize as readily as A1Rs, and clinically relevant doses have less peripheral side effects also 
making them a reasonable candidate for clinical application (Cunha 2005). 
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Epilepsy 
  
 The release of ATP and adenosine during seizure activity has been demonstrated, 
suggesting a role as a neuroprotective agent mitigating the damage of seizures, and mediating 
seizure termination (Dale and Frenguelli 2009).  The A1R specifically has been implicated in 
seizure suppression.  The pre and post-synaptic actions of the A1R, including a reduction in 
glutamate release and a hyperpolarization of the cell membrane, provide a hurdle which makes 
overexcitation more difficult (Gomes et al. 2011, Rosim et al. 2011).  While adenosine deficiency 
has been linked to epilepsy, and it is etiologically more relevant than current sodium channel 
blockers, the activation of A1Rs in a manner as coarse as the application of agonists incurs a 
wide range of side effects in the CNS and also peripheral tissues (including the heart).  
Fortunately, a more subtle influence of adenosine levels has been achieved through the 
manipulation of adenosine kinase (ADK) expression.  
 Astrocytes have more recently been recognized as significant contributors to 
transmission and network activity.  They are a significant source of adenosine through the 
release of ATP, and a prominent source of ADK.  The rapid clearance of intracellular adenosine 
intracellularly in astrocytes by ADK couples with their passive channels on the membrane to 
provide a gradient in which adenosine can be rapidly removed from the extracellular space.  
Excessive ADK activity can cause seizures by creating abnormally low levels of extracellular 
adenosine.  Astrogliosis, an increase in astrocyte number owing to neuron loss from traumatic 
events, can provide the circumstances in which ADK becomes overexpressed and extracellular 
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adenosine is cleared too exhaustively.  ADK overexpression in mice was sufficient to cause 
spontaneous seizures (Boison 2013).  Supporting the role of ADK expression clinically is the 
observation that temporal lobe epilepsy patients have lower adenosine levels and higher ADK 
expression (Boison 2013).  As might be expected, ADK inhibitors can indeed suppress seizures 
(Boison 2013). 
 Recently, a ketonergic diet (high-fat and low carbohydrate) has been found to 
suppress seizures by reducing adenosine kinase expression and increasing the activation of A1Rs 
in mice (Masino et al. 2011).  The ketonergic diet switches cellular metabolism away from 
glycolosis (which is ATP-producing) and toward one that increases fatty acids, lowers glucose, 
and increases ketone bodies.  A major consequence of this is a reduction in ADK expression.  
The result of decreased ADK expression is that more adenosine is available extracellularly to act 
upon A1Rs.  The ketonergic diet was not effective in mice with a full knockout of the A1R.  
Increased activation of A1Rs caused by lower ADK expression is seizure-suppressing.  The 
ketonergic diet’s subtle manipulation of A1R activation may avoid many of the negative side 
effects observed with pharmacological agents (Rho et al. 2013). 
 Adenosine is released in an activity-dependent manner, particularly during traumatic 
events where there is massive ATP expenditure and excessive excitation.  Its release in response 
to these events, combined with its powerful suppressant effects on excitatory transmission 
place it at center stage as an endogenous ‘emergency response’ system within the cortex.  
Epileptic seizures are typically cortical phenomena, and in light of the complexities of 
mechanisms by which adenosine exerts a neuroprotective/antiepileptic effect, an explicit 
demonstration of adenosine’s synaptic actions within the neocortex may help to clarify the 
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synaptic and network basis for seizure suppression.  Clearly astrocytic clearance of adenosine 
plays a role, but the mechanism by which restored A1R activation actually suppresses seizures is 
suggestive.  Decreased glutamate release and decreased cell excitability are both reasonable 
candidates, yet understanding of the pre and post synaptic actions of neocortical adenosine 
suffer from being mostly implied, rather than experimentally demonstrated. 
 
 Sleep 
 Due to the noted effects of the nonselective antagonist caffeine as a minor stimulant, 
and the ability of it and other adenosine receptor antagonists to promote wakefulness, 
adenosine has been implicated in sleep behavior.   
 Increasing adenosine levels in the brain promotes sleep while decreasing adenosine 
levels increases wakefulness (Bjorness and Greene 2009).  Consistent with this is the converse 
observation that adenosine levels rise during waking and decrease during sleep.  Specifically, 
rises during waking are seen in the basal forebrain and cortex whereas decreases during sleep 
are seen in the BF, cortex, brainstem, and hypothalamus (Bjorness and Greene 2009).  Sleep 
deprivation in specific causes a rise in adenosine levels within the basal forebrain and the 
neocortex (Porkka-Heiskanen et al. 1997, Strecker et al. 2000, Stenberg 2007).  Adenosine, by 
modulating transmission in the thalamus, hypothalamus, basal forebrain, and brainstem can 
influence the transition between behavioral states. 
 Thalamocortical (TC) and thalamic reticular nucleus (TRN) neurons display different 
modes of firing in response to inputs, depending on their resting potential.  At depolarized 
states they transmit spikes reliably (tonic firing), while highly hyperpolarized TC/TRN neurons 
34 
 
display more time between bursts, resulting in a shift to oscillatory burst firing and an initiation 
of delta waves transmitted to the cortex (Bjorness and Greene 2009, Halassa 2011).  In the 
lateral geniculate nucleus, adenosine has been demonstrated to act postsynaptically to increase 
K+ conductance and hyperpolarize cells, shifting their preference toward burst-firing (Pape 
1992).  Within the cortex, inputs from the thalamus are also modulated by adenosine.  In a 
thalamocortical slice preparation of mouse, the responses of thalamocortical inputs onto layer 4 
onto both interneurons and pyramidal neurons were measured.  Adenosine acting on 
presynaptic receptors at thalamocortical terminals reduced the release probability of glutamate 
onto both inhibitory cells and excitatory cells (Fontanez and Porter 2006).   
 The basal forebrain (BF) contains both cholinergic and noncholinergic neurons which 
project to the cortex.  These cholinergic inputs to the cortex are more active during waking and 
REM sleep than in NREM sleep.  Adenosine causes an inhibition in wake-promoting cholinergic 
basal forebrain neurons (Strecker et al. 2000, Bjorness and Greene 2009).  Local adenosine 
perfusion into the BF reduced wakefulness and cortical arousal.  In contrast, A1R antagonism did 
the opposite (Strecker et al. 2000).  Adenosine agonists can inhibit transmission in the 
mesopontine tegmentum as well.  The result of inhibition here is again a reduction in the 
activity of the cholinergic system, which would facilitate sleep.  Within the diagonal band of 
Broca (in the basal forebrain) and the mesopontine tegmentum, adenosine reduces excitability 
in part by acting postsynaptically through increased K+ conductance (Rainnie et al. 1994).  The 
hypothalamus contains hypocretin/orexin neurons which again are active specifically during 
waking (Bjorness and Greene 2009).  Adenosine here suppresses excitatory inputs to these 
neurons through presynaptic inhibition of glutamate release.  The hypocretin/orexin neurons 
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themselves demonstrated reduced postsynaptic Ca2+ currents in response to adenosine, through 
no GIRK mediated current was observed (Liu and Gao 2007).  Adenosine inhibiting glutamatergic 
and cholinergic transmission, and decreasing neuronal excitability in the above brain areas 
serves to inhibit arousal systems and excitatory inputs to cortex, promoting sleep. 
 In the ventrolateral preoptic area (VLPO) there exist ‘sleep-active’ neurons which are 
active, as indicated, primarily during sleep.  Upon adenosine application in this area, 
spontaneous IPSP/Cs were decreased whereas EPSP/Cs were unaffected.  The disinhibition of 
‘sleep-active’ neurons in the VLPO then serves to promote the behavioral state of sleep 
(Strecker et al. 2000, Morairty et al. 2004).  This preferential action of adenosine on inhibitory 
transmission is interesting because in other brain areas (such as hippocampus) adenosine 
preferentially inhibits excitatory transmission (Yoon and Rothman 1991).  The intriguing 
consequence of this action is that the end result is still somnogenic, and therefore in agreement 
with the roles of adenosine in sleep in other areas.  There also exist neurons in the 
preoptic/anterior hypothalamic area (POAH; ventral forebrain) which are primarily active during 
slow wave sleep.  Adenosine again activates these neurons indirectly through an inhibition of 
GABAergic transmission (Strecker et al 2000).  Adenosine then disinhibits ‘sleep-active’ neurons 
to promote sleep while simultaneously inhibiting arousal systems which when active promote 
waking. 
 Adenosine’s most generalizable effects, namely the inhibition of transmitter release 
and the reduction in postsynaptic excitability, have profound consequences due to the 
anatomical importance of the nuclei they act within.  In the thalamus, intrinsic properties of 
these neurons which allow them to fire in two states are directly modulated by the ability of 
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adenosine to hyperpolarize neurons and reduce cell excitability.  In the so-called arousal and 
somnogenic areas discussed, an inhibition or disinhibition through these general mechanisms 
contributes directly to the transition of behavioral state.  While receptor profiles and multiple 
sources of adenosine certainly create a diversity of scenarios, even a simple and straightforward 
action of adenosine mediated inhibition can have profound consequences when applied to 
specific circuits.  This highlights adenosine’s role as an important modulator, tuning the actions 
of other transmitter systems such as Acetylcholine, GABA, and glutamate. 
 
 Sleep Homeostasis 
 Adenosine also acts to modulate transmission within the state of sleep itself.  Within 
sleep higher adenosine concentrations promote deeper sleep and higher slow wave activity 
(SWA; 0.5-4 Hz range of the EEG during NREM sleep).  While not necessary for the production of 
SWA, A1Rs play a role in its modulation (Bjorness and Greene 2009).  A net potentiation of 
synapses cooccuring with an increase in sleep pressure is thought to occur during waking. A 
proposed role of sleep, and specifically slow-wave sleep, is that it restores metabolically 
sustainable synaptic distributions while maintaining the relative weights of synapses that 
presumably underlie memory.  SWA is characteristic of the EEG during NREM and is thought to 
underlie this homeostatic ‘synaptic downscaling’ (Tononi and Cirelli 2006).  Normal mice will 
respond to sleep deprivation (and increased sleep pressure) with increased SWA in subsequent 
sleep.  A1R knockout mice showed a largely absent SWA compensation after deprivation.   
 Following the knowledge that A1Rs play an important role in sleep homeostasis, the 
importance of astrocytic sources of adenosine in these processes was demonstrated. Mice in 
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which vesicular release from astrocytes was selectively impaired were utilized (dnSNARE mice; 
Halassa et al. 2009).  Adenosine, arising from vesicularally released ATP was found to be a major 
factor in A1R activation and subsequent modulation of sleep homeostasis in the cortex.  
DnSNARE expression did not significantly change sleep time or architecture, however sleep 
pressure was reduced.  This was demonstrated by a decrease in SWA, particularly in the lower 
frequencies.  Low frequency slow waves (<1 Hz) have been shown to be a cortical phenomenon, 
present even in the absence of thalamic input (Contreras and Steriade 1995).  Sleep deprivation, 
a manipulation which results in an increase in sleep pressure, is normally accompanied also by 
increased sleep time.  In contrast to their wildtype counterparts, dnSNARE mice did not respond 
to sleep deprivation with an increased total sleep time.  The A1R antagonist CPT administered to 
wildtype mice mimicked the phenotype of dnSNARE mice, while CPT given to dnSNAREs had 
little to no effect.  Sleep deprivation and increased sleep pressure also results in cognitive 
deficits, so behavioral assessments of the impact of impaired gliotransmission were assessed.  In 
a novel object recognition task, wildtype mice were impaired following sleep deprivation, 
whereas dnSNARE mice (demonstrating decreased sleep pressure) were not affected.  Again, 
manipulation of A1R by ligands to mimic the dnSNARE condition (lack of A1R activation) 
mimicked the phenotype of dnSNARE mice.  The mechanisms of how neocortical adenosine 
modulates this SWA is poorly understood.  Phasic release of D-Serine and ATP from astrocytes 
(Halassa 2011), alterations in the excitatory/inhibitory balance, and/or changes in neuronal 
excitability is likely to contribute, but explicit demonstration of many of these theories is lacking.  
These mechanisms would also rely on specific synaptic actions of adenosine, which are also 
poorly elucidated within the neocortex. 
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Within the Neocortex 
 Early electrophysiological research on purines in cerebral cortex documented the 
ability of adenosine and related purines to suppress excitatory transmission (Harms et al. 1978 
on adenosine's ability to inhibit noradrenaline, Kostopoulos and Phillis 1977, Stone and Taylor 
1980, Pedata et al. 1983 on the release of acetylcholine, Kostopoulos et al. 1989 and 
O'Shaughnessy et al. 1988 on suppression of epileptiform activity).  The results were consistent 
with more detailed subsequent research, namely adenosine and other purines act to suppress 
synaptic transmission, and are able to inhibit the release of glutamate, noradrenalin, and 
acetylcholine.  Thus adenosine came to be considered as a neuromodulator, with widespread 
and powerful effects on transmission. 
 In the neocortex, application of adenosine receptor agonists leads to a suppression of 
both excitatory transmission (specifically in layer 5; Brand et al. 2001, Murakoshi et al. 2001), 
and GABAergic transmission (Kruglikov and Rudy 2008, Kirmse et al. 2008 for the 
developmentally relevant inhibition of GABAergic transmission by adenosine during early 
postnatal development).  In regards to inhibitory transmission, GABAergic inputs from fast-
spiking interneurons onto layer 5 pyramidal cells of the somatosensory cortex were inhibited by 
adenosine.  The reduction in inhibitory postsynaptic currents (IPSCs) here was found to be due 
to presynaptic mechanisms (likely a reduction in release probability; Kruglikov and Rudy 2008).  
Regarding adenosine’s ability to inhibit excitatory transmission, EPSPs in layer 5 pyramidal 
neurons have been shown to be inhibited by adenosine (specifically through presynaptic A1Rs).  
In intracellular recordings from pyramidal cells in layer 5 of the associative frontal cortex, post-
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synaptic potentials (PSPs) evoked by stimulation in layer 1 were demonstrated to be suppressed 
by A1R activation (Brand et al. 2001).  In this study, the amplitude and slope of PSPs were 
decreased when the A1R agonist CPA was bath applied.  The NMDA and non-NMDA component 
of the PSP were not differentially affected which is explicable by invoking a strictly presynaptic 
site of action.  Further supporting this, no changes in membrane potential or input resistance 
were observed after application of the A1R agonist (Brand et al. 2001).  Layer 5 pyramidal cells 
of the visual cortex have also been studied.  Evoking excitatory postsynaptic currents (EPSCs) by 
stimulating neighboring layer 5 pyramidal cells, it was demonstrated that adenosine decreased 
the amplitude of elicited EPSCs and increased the paired-pulse ratio (PPR), indicating a 
presynaptic locus of action (Murakoshi et al. 2001).  In addition, adenosine reduced the 
frequency of miniature EPSCs recorded under application of 1uM TTX.  No effect of adenosine 
on the mean amplitude of miniature events was found, indicating no postsynaptic modulation 
of the EPSC.  More recently transmission from layer 4 onto layer 2/3 pyramidal cells in the 
somatosensory cortex has been studied.  Mice with impaired astrocytic vesicle release 
(dnSNARE mice), which subsequently show a lack of A1R activation, demonstrated reduced 
NMDAR function while AMPA currents remained unaffected (Deng et al. 2011).  In addition, 
mEPSC frequency was increased in dnSNARE mice, suggesting tonic activation of cortical A1Rs by 
astrocytic-derived adenosine suppressed presynaptic release.  The implication of A1Rs 
specifically is supported by the observation that A1R antagonism mimics the dnSNARE condition 
(Deng et al. 2011).  Again the locus of adenosine’s action appears to be presynaptic A1Rs. 
 There is notable heterogeneity of effects within the neocortex itself.  The magnitude 
of adenosine’s suppression and the locus of action (pre and post-synaptic) vary in different 
40 
 
preparations.  Within the neocortex, it has been shown that different layers may be 
differentially affected by adenosine.  Using optical imaging with voltage sensitive dye, these 
regional differences in the ability of adenosine to suppress transmission were investigated 
(Kovac et al. 2008).  Stimulation in layer 1/2 or in the border between white/grey matter was 
used to evoke activity in the slice which traversed the lamina of the cortex.  Adenosine 
significantly suppressed evoked activity in layers 4, and most profoundly in 2 and 3.  
Audioradiographic data in the visual cortex of the monkey has revealed distribution of A1Rs is 
highest in layer 2/3 and 5, and lowest in layer 4 (Chaudhuri et al. 1998).  The details of 
adenosine’s actions in any preparation, then, cannot be established through generalization, 
even across different synapses within the neocortex. 
 Our knowledge of the actions of adenosine in the neocortex is incomplete.  How 
adenosine effects synaptic transmission to layer 2/3 pyramidal neurons of the visual cortex 
remains largely unknown.  The primary source of feedforward inputs to layer 2/3 arises from 
neurons of layer 4 (which receive projections from the lateral geniculate nucleus; Tucker and 
Fitzpatrick 2004) Layer 2/3 neurons also have horizontal connections between each other, and 
mediate communication between cortical areas.  This connectivity makes them a likely 
candidate to mediate network activity such as global oscillations. 
 
Rationale for the current work  
 Different profiles of receptor expression set the stage for how adenosine is able to 
influence transmission.  For example, interaction of the A2AR with other pre, post, and 
extrasynaptic receptors results in different binding profiles and transduction mechanisms, and 
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very different consequences for transmission (Orrú et al. 2011).  Within the striatum densely 
expressed postsynaptic A2ARs integrate dopaminergic transmission on medium spiny neurons 
while incoming cortico-striatal glutamate terminals express A2ARs and A1Rs which operate 
together to control glutamate release locally.  Within the hippocampus it has been proposed 
that sparse, presynaptically located A2ARs serve to facilitate transmission specifically during high 
frequency stimulation at homosynaptic sites.  Knowledge of the expression of A2AR mRNA within 
the neocortex (Dixon et al. 1996, Fredholm et al. 20011), informs us little of the function of 
these receptors.  The vast heterogeneity of A1R and A2AR expression, transduction, and 
interactions is the basis of a need for explicit demonstrations of synaptic capabilities of 
adenosine in any brain area of interest. 
 Adenosine’s modulation of plasticity outcomes is well documented in the 
hippocampus, but its role in neocortical plasticity is unknown.  Because understanding of 
adenosine at the synaptic level in neocortex is understudied, educated theories about 
modulation of plasticity in the cortex are missing critical groundwork, yet one may not 
inappropriately generalize from the hippocampus.  The well-documented, intricate, and unique 
interaction between dopamine and adenosine in the striatum further highlight the incredible 
complexity of receptor-receptor interactions and integration of modulatory systems.  It is likely 
that adenosine’s modulation of transmitter systems involves complex receptor interactions in 
other brain areas as well.  An explicit demonstration of what receptors for adenosine are 
functional and their pre- or postsynaptic location is a prerequisite for more detailed 
investigations into how these receptors interact with other transmitter systems.  Again, this 
foundation is lacking within the neocortex.  Adenosine modulation of neocortical slow waves is 
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demonstrated, yet again, the synaptic basis which makes this modulation possible is 
unexplored.  The profound impact of adenosine on seizure activity is well known but typically 
assessed at a more macroscopic level than the synapse.  Proposals for mechanism are 
suggestive, supported by knowledge of hippocampal and subcortical cellular actions.  Known 
behavioral and physiological actions of adenosine in the neocortex all share a gap in 
understanding of the synaptic basis of their action.  The work that has been done on the 
synaptic level within the neocortex has focused mostly on incoming thalamocortical inputs, or 
layer 5 pyramidals.  Knowing there is a heterogeneity of adenosine’s impact across the lamina, 
the synaptic actions of adenosine in the cortex are largely unexplored. 
 The rationale for explicit characterization of a given synapse’s ‘adenosine profile’ 
should then be clear.  Important physiological events within the neocortex, such as sleep 
homeostasis, network oscillations, plasticity, and neuroprotection have been demonstrated 
explicitly to (or are likely to) be modulated by adenosine.  The lack of electrophysiological 
characterization of adenosine’s actions in the neocortex then is a clear missing link.  This link has 
been implicitly supplied by the assumption adenosine acts here as in other brain areas, but the 
experimental evidence exposes the dangers of such assumptions and questions the existence of 
a ‘typical’ role for adenosine. 
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Introduction: the present work 
 The primary aim of the present work is to gain explicit knowledge of the actions of 
adenosine in the neocortex on a cellular level.  Here, we investigate the effects of adenosine on 
evoked excitatory postsynaptic potentials (eEPSPs), spontaneous miniature postsynaptic 
potentials (mEPSPs), and membrane properties in layer 2/3 pyramidal cells of the rat visual 
cortex in vitro.  We show that adenosine suppresses excitatory synaptic transmission in layer 2/3 
of the visual cortex. Adenosine acts presynaptically to reduce release probability and 
postsynaptically to decrease input resistance and hyperpolarize the cell.  In agreement with the 
A1R's role in the inhibitory actions of adenosine, we find selective blockade of this receptor by 
DPCPX to prevent the actions of adenosine in our preparations.  Unlike other work in the cortex, 
we found a robust action of adenosine (through the A1R) on membrane properties.  There was 
hyperpolarization of the membrane and a reduction in input resistance consistent with the 
activation of K+ conductance.  We also provide what is (to our knowledge) the first 
demonstration of A2AR mediated actions on basal transmission in the neocortex.  Using A2AR 
antagonist SCH 58261, we found high concentrations of adenosine activate A2ARs which exert a 
facilitatory effect on transmission. 
 
Methods 
Slice Preparation 
All experimental procedures used in this study are in compliance with the US National 
Institutes of Health regulations and were approved by the Institutional Animal Care and Use 
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Committee of the University of Connecticut. Details of slice preparation and recording were 
similar to those used in previous studies (Volgushev et al. 2000; Lee et al 2012).  Wistar rats (15-
32 days old) were anaesthetized with isoflurane, decapitated, and the brain was quickly 
removed and placed into an ice-cold oxygenated artificial cerebrospinal fluid solution (ACSF), 
containing, in mM: 125 NaCl, 25 NaHCO3, 25 glucose, 3 KCl, 1.25 NaH2PO4, 2 CaCl2, 1 MgCl2, 
bubbled with 95% O2/5% CO2 , pH 7.4. Coronal slices (350 μm thickness) containing visual cortex 
were prepared from the right hemisphere. Slices were allowed to recover for at least an hour at 
room temperature. For recording, individual slices were transferred to a recording chamber 
mounted on an Olympus BX-50WI microscope equipped with infrared differential interference 
contrast (IR-DIC) optics. In the recording chamber slices were submerged in oxygenated ACSF at 
28°-32°C.  
 
Intracellular recording and synaptic stimulation 
Layer 2/3 pyramidal cells from visual cortex were selected for recording in the whole cell 
configuration. Identification of pyramidal neurons using DIC microscopy was reliable as 
demonstrated in our previous work with biocytin labelling and morphological reconstruction of 
recorded neurons (Volgushev et al 2000). Intracellular pipette solution contained, in mM: 130 K-
Gluconate, 20 KCl, 10 HEPES, 10 Na-Phosphocreatine, 4 Mg-ATP, 0.3 Na2-GTP, (pH 7.4 with KOH). 
Two pairs of stimulating electrodes (S1 and S2) were placed in Layer 4, below the Layer 
2/3 recording site (Fig 1). Stimulation current intensities were adjusted to evoke monosynaptic 
excitatory postsynaptic potentials (EPSPs) in the recorded neuron.  In some cases picrotoxin 
(100 µM Sigma) was used to block inhibitory transmission.  We used paired-pulse stimulation 
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protocol with a 50 ms inter-pulse interval. Paired stimuli were applied to S1 and S2 in 
alternating sequence once per 7.5 seconds, so that each input was stimulated with paired 
pulses each 15 seconds. 
For experiments measuring spontaneous miniature EPSPs (mEPSPs), tetrodotoxin (TTX; 
0.1-0.5 µM, Tocris) was added to the extracellular solution, at least 25 minutes before 
recordings were started.  All drugs were bath applied. All chemicals were obtained from Sigma-
Aldrich unless stated otherwise.  Adenosine was dissolved in ACSF to a 1 mM stock before being 
applied to the bath.  DPCPX was dissolved in a 60% ethanol solution to a 0.5 mM stock.  Final 
ethanol concentration in the bath ranged from 1.8x10-4 to 1.8x10-2 % for 1.5-150 nM DPCPX.  
SCH-58261 was dissolved in 100% ethanol to a 2.5mM stock.  Final bath concentration of 
ethanol in SCH-58261 experiments was 12x10-4 %. 
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Data analysis 
Data analysis was made using custom-written programs in MatLab ( © The MathWorks, 
Natick, MA, USA).  All inputs included in the analysis fulfilled the criteria of (1) stability of EPSP 
amplitudes during the control period, (2) stability of the membrane potential throughout the 
recording, and (3) stability of the onset latency and kinetics of the rising slope of the EPSP. EPSP 
amplitudes were measured as the difference between the mean membrane potential during 
two time windows. The first time window was placed before the EPSP onset and the second 
time window was placed on the rising slope of the EPSP, just before the peak.  Amplitude of the 
 
Fig 1.  Scheme of the location of stimulation and recording electrodes in our neocortical slices.  
Recordings were made from layer 2/3 pyramidal neurons while the two stimulation electrodes (S1 and 
S2) were placed in layer 4. 
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second EPSP in paired-pulse stimulation paradigm was measured using windows of the same 
duration, but shifted by the length of the inter-pulse interval (50 ms).  
Spontaneous mEPSPs were detected as following.  Two windows (a window 1, ‘baseline’, 
2.5 ms in width and a window 2, ‘amplitude’ 1.5 ms in width) were spaced 2.5 ms and swept the 
recorded trace.  Within each window the mean membrane potential was measured.  When the 
difference between the mean membrane potential in the ‘amplitude’ and the ‘baseline’ window 
(window 2 – window 1) was at least 0.2 mV but no more than 2mV, an event was detected.  
After this automatic detection, all detected events were visually checked for their shape, and 
erroneously detected traces were excluded from analysis.  We measured frequency of mEPSCs, 
amplitude of each event and compiled their amplitude distributions. From the amplitude 
distributions, we calculated the the skew of the distribution and determined median. 
Significance tests were accomplished utilizing Student's t-tests or one-way ANOVAs with 
Post-hoc comparisons (Dunnett’s and Tukey’s HSD).  Error bars represent the standard error of 
the mean (± SEM).  
Results 
 Adenosine reduces the amplitude of evoked EPSPs and increases the paired pulse ratio 
 To study the effects of adenosine on synaptic transmission to layer 2/3 pyramidal 
neurons we recorded EPSPs evoked by paired-pulse electric stimuli in control and during bath 
application of adenosine (Sigma-Aldrich) at different concentrations.  To determine an effective 
concentration, we used bath application of 5 µM to 50 µM adenosine (Fig. 2).   Already with the 
lowest tested concentration of 5 µM, adenosine induced a clear decrease of the EPSP amplitude 
to 64.3 ± 4.3% of baseline (p <0.001).  Application of increasing concentrations of adenosine led 
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to a progressive reduction of the EPSP amplitude (Fig 2A, B).  20 µM of adenosine had a robust 
effect, reducing the EPSP amplitude to 32 ± 4.6% of baseline (p < 0.001). This concentration was 
selected for further experiments. 
 The reduction in EPSP amplitude by adenosine was accompanied by an increase in the 
paired-pulse ratio (PPR; Figure 2B). The PPR is an index of release that is inversely related to the 
release probability (Pr) at a synapse (Stevens 1993; Voronin 1993).  The increase in the PPR is 
suggestive of a decrease in release probability.  Changes in the EPSP amplitude observed during 
adenosine application were negatively correlated with the changes in the PPR, indicating the 
adenosine acted on presynaptic receptors to reduce release probability (Fig 5, open circles; r = -
0.620, n = 39, p < 0.001)  
49 
 
 
  
 
 
Fig 2.  Adenosine reduces evoked EPSP amplitude and increases paired-pulse ratio (PPR) in a 
reversible and concentration dependent manner.  
A. (Above) Traces of averaged EPSPs evoked in a layer 2/3 neuron from visual cortex by paired stimuli 
(50 ms interpulse interval) in control and through increasing concentrations of adenosine. (Below) 
The time course of amplitude changes of the responses to the first pulse in a pair (EPSP1, % of 
control). Data for same cell.   
B. Changes of the amplitude of EPSP1, EPSP2 and paired-pulse ratio (PPR) induced by increasing 
concentration of adenosine. EPSP amplitudes were normalized by the amplitude of the EPSP1 in 
control for each cell, and then averaged for N=5 neurons (10 inputs).  Adenosine reduces EPSP 
amplitude and increases PPR in a concentration dependent and reversible manner. 
Significance denoted as * p<0.05; **p<0.01; *** p<0.001.  Significance for EPSP2 mirrored EPSP1 for 
all concentrations of adenosine tested, yet “***” is omitted for clarity. 
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 Adenosine reduces the frequency of spontaneous miniature EPSPs 
 To corroborate the evidence that presynaptic mechanisms are involved in adenosine’s 
effects on synaptic transmission we recorded miniature EPSPs in the presence of 0.5 µM 
tetrodotoxin (TTX) in the bath. Figure 3A illustrates membrane potential traces and detected 
mEPSPs. Application of adenosine (20 µM) led to a decrease of the frequency of mEPSPs (Fig. 
3A, C). On average, mEPSP frequency decreased from 9.0 ±0.9 events/sec in control to 6.5 ±0.7 
events/sec (when normalized, 80.4 ±4.5% of baseline frequency) during adenosine application 
(Fig 3C; n = 20, p < 0.01). After washout of adenosine, mEPSP frequency recovered to 9.5 ±1.2 
events/sec (when normalized, 104.3 ±9.8% of baseline frequency).  
 Adenosine application led to reduction of frequency of mEPSPs of all amplitudes: the 
amplitude distributions were scaled down, but their skew did not change (2.9 ±0.3 vs 3.1 ±0.4; 
n.s.). There was however a very small yet significant reduction in the median amplitude of 
events, from 0.29 ±0.02 mV to 0.28 ±0.02 mV, (or when normalized, to 95.0 ±1.2% of baseline; 
Fig 3D n = 20, p < 0.01).  This reduction of the median mEPSP amplitude may be attributable to 
a ~20% decrease of the input resistance of neurons during adenosine application (see below).  
 
 A1R blockade prevents adenosine’s effects on evoked EPSPs 
 Which receptors mediate adenosine’s effects on synaptic transmission? In situ 
hybridization, reverse transcription-polymerase chain reaction, binding studies, and other 
51 
 
biochemical methods have demonstrated high expression of A1Rs in the neocortex (Dixon et al. 
1996, Fredholm et al. 20011).  These receptors are classically responsible for the inhibitory 
actions of adenosine.  Therefore we first studied how blockade of A1Rs affect the inhibitory 
actions of adenosine on synaptic transmission. We applied 20 µM adenosine on the background 
of varying concentrations of the selective A1R antagonist 8-Cyclopentyl-1,3-dipropylxanthine 
(DPCPX).  DPCPX blocked the adenosine-induced reduction in EPSP amplitude in a concentration 
dependent manner (Fig 4).  The effect of DPCPX was clear even at the lowest concentration 
tested (1.5 nM), and in the presence of 30 nM DPCPX, application of 20 µM adenosine failed to 
induce significant reduction of EPSP amplitude. Figure 4B displays summary data on the EPSP 
amplitude and PPR changes during application of 20 µM adenosine as a percent of baseline.  In 
control conditions (no DPCPX), 20 µM adenosine reduced the EPSP amplitude to 39.4 ± 4.6% of 
baseline (Fig. 4B, C; p<0.01, n= 13; significant reduction from baseline denoted in C).   On the 
background of 1.5 nM DPCPX adenosine reduced the EPSP amplitude to 65.4 ± 6.7% of baseline. 
This reduction was significantly smaller than in the control group (Fig 4B, p < 0.05).  On the 
background of 30nM DPCPX, adenosine reduced the EPSP amplitude to only 93.4 ± 6.6% of 
baseline, again significantly less than in the control condition (Fig 4B; p < 0.001).  In fact, 30 nM 
DPCPX was sufficient to completely block the effect of adenosine on EPSP amplitude.  No 
significant reduction in EPSP amplitude was found after application of adenosine on the 
background of 30nM DPCPX (Fig 4C, top).  
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Fig 3. Adenosine reduces miniature EPSP (mEPSP) frequency and decreases the median amplitude 
of events. 
A.  Example traces of spontaneous activity from one cell in control and in the presence of 20 µM 
adenosine.  The slopes of detected mEPSPs are highlighted in pink and marked with arrows. 
B.  Examples of individual (top) and averaged (bottom; N=509 events for CTRL; N=355 events for Ado) 
miniature EPSPs and their amplitude distributions from 2.5 min recordings in control and during 
application of 20 µM adenosine.  
C, D.  Changes of the frequency of mEPSPs (C) and their median amplitude (D) during application of 
20 µM adenosine and washout.  Both the reduction in frequency of events and median amplitude of 
events recovered after washout of adenosine.  Averaged data for N=18 cells. 
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 The attenuation of the adenosine-induced reduction in EPSP amplitude in the 
presence of DPCPX was accompanied by an attenuation of the adenosine-induced increase in 
PPR.  Figure 4B (bottom) shows a summary of the PPR changes induced by application of 20 µM 
adenosine on the background of different concentrations of DPCPX.  In control conditions (no 
DPCPX), application of 20 µM adenosine increased the PPR to 144 ± 12.9% of baseline (Fig 4B, C; 
p < 0.01, significant increase denoted in C).  In the presence of 1.5 nM DPCPX, the increase was 
smaller (122 ± 6.6%), and became significantly different from the control group at 7.5 nM (108 ± 
6.1% of baseline; p < 0.05). With 30 nM DPCPX, adenosine did not elicit any significant increase 
in the PPR, just as it did not depress the EPSP amplitude (Fig 4B,C).  
 In experiments with adenosine applied alone or in the presence of DPCPX, the 
changes in EPSP amplitude were inversely proportional to the PPR changes (Fig 5).  A strong 
negative correlation between EPSP amplitude changes and PPR changes was found in DPCPX 
experiments (r = -0.693, n = 52, p < 0.001), and experiments in which adenosine was applied 
alone at different concentrations (r = -0.620, n = 39, p < 0.001 for concentration dependence 
experiments and r = -0.546, n = 13, p < 0.05 for the control group for DPCPX experiments).  The 
correlation remained strong when all groups were pooled together (r = -0.644, n = 104, p < 
0.001) indicating that the relationship between EPSP/PPR change is maintained when 
manipulating the activation or blockade of A1Rs by various ligands.  These results suggest that 
presynaptic A1Rs are mediating adenosine’s effects on EPSP amplitude by modifying release 
probability. 
 Adenosine-induced decrease of the frequency of mEPSPs was also found to be 
mediated by A1 receptors.  On the background of 30 nM DPCPX, application of 20 µM adenosine 
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failed to induce any changes of the frequency of mEPSPs (9.8 ±1.5 vs 9.6 ±1.6 events/sec, n= 15, 
data not shown).  
 To uncover any tonic activation of A1Rs, DPCPX was applied to the slice without the 
application of adenosine.  The application of 7.5 nM DPCPX on the background of 0.1µM TTX 
and 100 µM picrotoxin led to a non-significant increase of excitatory mEPSP frequency from 7.9 
± 1.9 events/sec to 10.9 ± 3.1 events/sec (n = 6, n.s.; data not shown).  An increase in mEPSP 
frequency would suggest that the blockade of A1Rs by DPCPX relieves a tonic activation of these 
receptors and thus tonic inhibition of release by adenosine.  The experiment described here 
trended toward this result but lacked statistical power.  Although suspected, the present results 
cannot confirm physiologically relevant tonic levels of adenosine in the neocortex in vitro. 
 Taken together, the results of experiments with DPCPX demonstrate that the 
inhibitory effects of adenosine on synaptic transmission to pyramidal neurons in layer 2/3 are 
mediated via activation of presynaptic A1 receptors which have a suppressive effect on release 
probability.  
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Fig 4.  A1 receptor antagonist DPCPX blocks adenosine’s effects on synaptic transmission.  
A.  Example traces of evoked EPSPs before (black) and after application of 20 µM adenosine (red) on the 
background of DPCPX. Data for different concentrations of DPCPX are from different cells.  
B.  Concentration dependence of the blockade of adenosine’s effects on synaptic transmission by DPCPX. 
Changes of EPSP1 amplitude (top) and PPR (bottom) induced by bath application of 20 µM adenosine in 
control (no DPCPX) and on the background of different concentrations of DPCPX. Number of synaptic inputs 
studied with each DPCPX concentration is indicated in parentheses in the top plot.  Solid curves show sigmoid 
fit to the data points.  Significance was calculated for the difference between percent reduction of EPSP 
amplitude by 20 µM adenosine in control group vs. the reduction in the presence of DPCPX.  
C.  Effects of 20 µM adenosine on synaptic transmission are completely blocked by 30 nM DPCPX. Data from 
B, with washout of adenosine. Changes of EPSP1 amplitude (top) and PPR (bottom) during application and 
washout of 20 µM adenosine, in control (black bars) and in the presence of 30 nM DPCPX (grey bars). 
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Fig 5.  Adenosine induced changes in EPSP amplitude are inversely related to changes in PPR.  
Changes in PPR plotted against changes in the EPSP1 amplitude.  For experiments with the 
application of adenosine of different concentrations (5-50 µM, open circles), changes in PPR and 
EPSP1 amplitude were correlated (r = -0.62, n = 39, p < 0.001). These changes were again correlated 
in experiments utilizing application of 20 µM adenosine on the background of different 
concentrations of DPCPX (1.5 - 150 nM, closed circles; r = -0.69, n = 52, p < 0.001).  The control group 
for these experiments, which utilized 20 µM adenosine but no DPCPX, also yielded a correlation 
between PPR change and EPSP1 amplitude change (r = -0.55, n = 13, p < 0.05).  The relationship 
between changes in EPSP amplitude and PPR is linear, and manipulation of A1R activation by different 
ligands alters these measures in a way that maintains this relationship. 
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 Adenosine reversibly hyperpolarizes the membrane and decreases the input resistance 
of layer 2/3 pyramidal neurons 
 In addition to the presynaptically mediated effects on synaptic transmission, 
adenosine application led to a decrease of the input resistance and hyperpolarization of the cell 
membrane in layer 2/3 pyramidal neurons.  Input resistance was calculated from membrane 
potential responses to small steps of positive and negative current applied through the 
recording electrode (Fig 6A).   During application of 20 µM adenosine the input resistance of the 
neurons decreased from 396.5 ± 44.4 Mohm to 314.0 ± 36.3 MOhm (Fig 6B, right; n = 14 p < 
0.001).  The decrease of the input resistance could have been the reason for the minor decrease 
of the median amplitude of spontaneous mEPSPs during adenosine application described 
above. The resting membrane potential was hyperpolarized during adenosine application from -
65.3 ± 1.5 mV to -67.7 ± 1.8 mV (Fig 6B, left; n = 14 p < 0.01).  The adenosine elicited changes of 
the membrane potential and of the input resistance were absent when 20 µM adenosine was 
applied on the background of 30 nM DPCPX (n = 13; data not shown).  This suggests these 
effects are also mediated by the A1R. 
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Fig 6.  Adenosine decreases input resistance and causes hyperpolarization in pyramidal neurons 
from layer 2/3. 
A.  Membrane potential response of a pyramidal neuron from layer 2/3 to current steps in control, 
during application of 20 µM adenosine, and after washout. Decreased slope of the voltage-current 
relationship during adenosine application (red) indicates a decrease of the input resistance. 
B.   Changes of the membrane potential (left) and input resistance (right) during adenosine 
application and washout. Individual data for N=14 neurons (grey) and their average (black).  20  µM 
adenosine hyperpolarizes cells and decreases their input resistance.  Washout of adenosine 
demonstrates the reversibility of these effects. 
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 Effects of high concentration of adenosine on synaptic transmission 
 In order to discover a maximal effect of adenosine, we conducted a series of 
experiments which included high concentrations of adenosine (100 and 150 µM).  On 18 inputs 
from 14 cells, we bath applied 20, 100 and 150 µM adenosine and recorded evoked activity and 
membrane properties (Fig 7).  Increasing adenosine concentration from 20 µM to 100 µM led to 
a significant decrease of EPSP amplitude from 58.0 ± 5.3% to 33.9 ± 6.1 % of the control (Fig. 7A, 
p<0.001). In 2 out of 18 cases, responses were completely abolished during application of 100 
µM adenosine, but recovered upon wash out. Further increase of adenosine concentration to 
150 µM did not result in a further significant decrease of response (28.3 ± 5.4% of the baseline), 
and did not increase the proportion of inputs in which responses were completely abolished.  
 The input resistance of the membrane followed similar concentration dependence as 
the EPSP (Fig 7C): significantly decreasing from control to 20 µM adenosine, and again from 20 
µM to 100 µM adenosine.  There was no significant change between 100-150 µM adenosine 
however, suggesting a saturating or nearly saturating effect of adenosine on input resistance.  
The hyperpolarization of the cell caused by the application of adenosine appears to be the most 
easily saturated measure of adenosine’s actions.  After an initial hyperpolarization upon 
application of 20 µM adenosine, membrane potential did not hyperpolarize any further upon 
increasing adenosine concentration to 100 and then 150 µM (Fig 7B).  Because evoked activity 
was not blocked in these experiments, the membrane potential expressed stronger fluctuations 
(as indicated by larger standard error of these measurements) as compared to experiments 
conducted under TTX (see Fig. 6).  The possibility of a small effect size being masked by large 
variability cannot be excluded. 
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 Functional A2A receptors are present in layer 2/3 of neocortex 
 Results presented so far show that A1R activation plays a major role in mediating 
suppressive effects of adenosine on excitatory synaptic transmission in our preparation.  
Evidence obtained using immunochemical methods and binding of A2AR ligands in 
synaptosomes suggests presence of A2ARs in the cerebral cortex albeit at much lower levels than 
for example, in the striatum (Lopes et al. 1999, Marchi et al. 2002, Lopes et al. 2004).  The 
activation of A2ARs is associated with a facilitation of excitatory transmission, which is in 
opposition to A1R effects.  Because affinity to adenosine of A1Rs is about an order of magnitude 
higher than of A2ARs, and the expression of A1Rs in the cortex is much higher than other 
subtypes (Ciruela et al. 2006, Ciruela et al. 2011, Fredholm et al. 20012), effects of low 
concentrations of adenosine might have been due to A1R activation.  High concentrations (100-
 
 
 
Fig 7.  High concentrations of adenosine reveal a saturating effect on reduction of EPSP amplitude, 
hyperpolarization of membrane, and decrease in input resistance.  
A.  Average reduction in evoked EPSP amplitude as percent of baseline during a bath application of 20, 100, and 
150 µM adenosine reveal an upper limit on suppression of the EPSP.  11% (2 of 18) inputs were totally silenced 
by 100 µM adenosine, yet returned upon washout. 
B, C.  Average changes in membrane potential (B) and input resistance (C) before, during, and after adenosine 
application.  Concentrations of adenosine needed to achieve a maximal effect on hyperpolarization were lower 
in comparison to concentrations needed to reach maximal effects on reduction of EPSP amplitude and input 
resistance.  
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150 µM) of adenosine could activate both A1 and A2A receptors.  We questioned if at such high 
concentrations adenosine has saturated the A1Rs but also activated facilitatory A2ARs.  In this 
scenario the maximal reduction in EPSP amplitude elicited by A1R activation would be curbed by 
A2AR activation.  The effect of adenosine on EPSP amplitude described in Fig. 7 would then be a 
combination of inhibitory effect of A1R activation with a smaller facilitatory component 
produced by A2AR activation.  If this is the case, then under high concentrations of adenosine, 
the blockade of A2ARs should further reduce the amplitude of the EPSP.  To test this conjecture, 
we conducted a series of experiments in which application of 150 µM adenosine was followed 
by application of the selective A2AR antagonist SCH58261 (30 nM).  As described above, 
application of 150 µM adenosine profoundly reduced the EPSP amplitude (Fig 8; average of 
36.8± 7.6% of baseline; p <0.001).  Addition of SCH58261 elicited a small yet highly significant 
further reduction in the EPSP amplitude (to an average of 29.2 ± 6.6% of baseline; p <0.001).  
This suggests functional A2ARs are present in the neocortex, where they act in opposition to 
A1Rs to modulate excitatory transmission.  Subsequent addition of A1R antagonist DPCPX, and 
thus blockade of both A1 and A2A receptors was expected to relieve EPSPs from suppression. The 
EPSP amplitude increased after addition of 30 nM of DPCPX. However, the recovery was not 
complete, (only to 59.1 ± 9.8% of baseline). We attribute the incomplete recovery to the 
inability of the competitive A1R antagonist DPCPX to completely block the activation of A1Rs by 
150 µM adenosine.  Whereas 30 nM DPCPX was sufficient to block the effects of 20 µM 
adenosine (Fig. 4), it was not enough to compete with 150 µM.  
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Fig 8. On the background of a saturating concentration of adenosine, blockade of facilitatory A2A 
receptors by SCH58261 leads to further reduction of EPSP amplitude.  
Average reduction in evoked EPSP amplitude as percent of baseline (n = 16 inputs from 13 cells).  
After application of 150 µM adenosine, 30nM SCH58261 reduced the EPSP amplitude further, 
suggesting that under a high concentration of adenosine, the suppressive effect of inhibitory A1Rs is 
curbed by the activation of facilitatory A2A receptors.  
 
63 
 
Discussion 
 Results of the present study demonstrate that in rat visual cortex, adenosine 
suppresses synaptic transmission to layer 2/3 pyramidal neurons, decreases their input 
resistance and leads to membrane hyperpolarization. These pre- and postsynaptic effects of 
adenosine are mediated predominantly by A1 receptors. Our results also present evidence for 
functional A2A receptors that are activated in cortical neurons at high concentrations of 
adenosine.  
 
Presynaptic action of adenosine:  a reduction in release probability. 
  The most pronounced effect of adenosine application in layer 2/3 of the rat visual 
cortex was the suppression of synaptic transmission.  Adenosine reduced the evoked EPSP 
amplitude in a concentration dependent and reversible manner.  Concurrent with the reduction 
in the EPSP amplitude was an increase in the paired-pulse ratio. Because the paired-pulse ratio 
is inversely related to release probability (Voronin 1993; Murthy et al. 1997, Dobrunz and 
Stevens 1997, Oleskevich et al. 2000), these results suggest that an inhibition of transmission 
concurrent with an observed increase in the PPR was due to a reduction in release probability. 
This conclusion is consistent with prior data showing that adenosine and A1R agonists can 
increase the paired-pulse facilitation in the hippocampus and in layer 1 and 5 of the visual 
cortex (Dunwiddie and Haas 1985, Murakoshi et al. 2001, Kirmse et al. 2008).  In agreement 
with this view, we found that 20 µM adenosine reduces the frequency of spontaneous mEPSPs, 
which reflects presynaptic properties.  Other groups as well have witnessed adenosine’s ability 
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to change the frequency of spontaneous mEPSPs (Scanziani et al. 1992, Murakoshi et al. 2001, 
Deng et al. 2011,). 
 These effects of adenosine were mediated by the A1Rs, as they were abolished by 
application of the selective A1R antagonist DPCPX (30 nM).  In hippocampus, presynaptic A1 
receptors mediate inhibitory effects on synaptic transmission by reducing the influx of calcium 
through voltage-dependent calcium channels (VDCCs; Wu and Saggau 1994, Wu and Saggau 
1997, Gundlfinger 2007), or by modulation of release machinery downstream from Ca2+ influx 
(Wu and Saggau 1997, Scanziani et al. 1992, Deng et al 2011).  In both cases, the result of this 
presynaptic inhibition would be a reduction of release probability.  
 Our results on the presynaptic effects of adenosine most closely correspond with 
Murakoshi et al. 2001.  Upon adenosine application in layer 5 neurons of rat visual cortex they 
found a reduction in evoked EPSC amplitude, an increase in the paired-pulse ratio, and a 
decrease in miniature EPSC frequency.  However, they report only presynaptic changes, and did 
not see any changes in membrane conductance or an effect on the mean mEPSC amplitude.  
Layer/region-specific effects of adenosine have been demonstrated in neocortex and 
hippocampus (Kovac et al. 2008).  In their experiments, adenosine induced the most significant 
suppression of transmission in layer 2/3 of the neocortex, consistent with the demonstration of 
highly concentrated adenosine expression in layers 2/3 in visual cortex (Chaudhuri et al. 1998).  
Taken together with the present work, these results suggest adenosine acts differentially in 
different layers of the neocortex.   
 In the hippocampus, a tonic inhibition of synaptic transmission by endogenous 
adenosine acting on the A1R is documented both in vivo and in vitro (Dunwiddie and Diao 1994, 
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Wu and Saggau 1994, Lopes et al. 2002, Manita et al 2004).  Work with mice in which astrocytic 
vesicle release is impaired has suggested that adenosine derived from astrocitic ATP affects 
neurotransmission by providing an adenosine ‘tone’ to the neocortex (Halassa et al. 2009).  
Increase in the frequency of spontaneous mEPSPs upon application of DPCPX in the absence of 
exogenously applied adenosine lends support to this notion. Presence of the tonic inhibition of 
synaptic transmission by endogenous adenosine in the neocortex would substantiate the role of 
adenosine as a ubiquitous and persistent modulator of synaptic transmission. 
 
Postsynaptic actions of adenosine on layer 2/3 pyramidal neurons 
 Adenosine hyperpolarized layer 2/3 pyramidal neurons and decreased their input 
resistance, suggesting functional postsynaptic receptors.  None of these effects were observed 
during application of adenosine on the background of A1R blockade by DPCPX, suggesting that 
they were mediated by A1 receptors.  Indeed, A1Rs activate potassium currents through the 
activation of G-Protein coupled inwardly rectifying potassium channels (GIRKs; Trussel and 
Jackson 1985, Trussel and Jackson 1987, Greene and Haas 1991, Thompson et al. 1992, 
Takigawa and Alzheimer 1999). The resulting increase of K+ conductance can explain the 
decrease in input resistance and hyperpolarization of the membrane potential. These changes 
of membrane properties may underlie a small decrease in median mEPSP amplitude observed in 
experiments with spontaneous events.  Interestingly, no postsynaptic effects of adenosine were 
found in layer 5 neurons of rat visual or associative frontal cortex (Murakoshi et al., 2001, Brand 
et al. 2001), and have been found only in some neurons of layer 4 of the barrel cortex (spiny 
neurons but not interneurons; Feldmeyer et al. Neuroscience 2012 abstract).  Our 
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demonstration of postsynaptic actions in layer 2/3 then is layer-specific and may underlie 
increased inhibition of transmission in this region. 
 
A role for A2A receptors in neocortex?  Insight from other brain areas. 
 Our results provide evidence for functional A2A receptors in the neocortex. Increasing 
adenosine concentration from 100 to 150 µM failed to induce further significant reduction of 
EPSP amplitude.  However, application of a selective A2AR antagonist SCH58261 on the 
background of 150 µM adenosine led to a further reduction of EPSP amplitude, suggesting high 
concentrations of adenosine increased EPSP amplitude via A2ARs.  
 The dense expression of A1Rs in the neocortex far outweighs the presence of A2ARs.  
A2ARs then are likely to be strategically located and activated only under specific circumstances.  
Insight from known A1R and A2AR actions offer a possible scenario. At low concentrations, 
adenosine activates high-affinity A1 receptors, which suppress synaptic transmission.  High 
concentrations of adenosine (100-150 µM) activate also A2ARs that oppose suppressive effects 
of A1Rs.  Activation of A2ARs can enhance glutamate release (Marchi et al. 2002).  Interaction 
between A1Rs and A2ARs has been directly demonstrated in synaptosomes extracted from 
cortical and hippocampal regions from young adult rats. In this preparation, activation of A2ARs 
led to a protein kinase C dependent decrease of the binding affinity for ligands of A1Rs (Lopes et 
al. 1999).  In striatal neurons, A1Rs and A2ARs can form heteromers in the membrane in which 
A2AR activation decreases the affinity of the A1R for its agonists through direct intramembrane 
receptor-receptor interactions (Ciruela et al. 2006, Ferré et al. 20071,2, Ciruela et al. 2011).  
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Application of SCH 58261 on the background of 150 µM adenosine blocks A2AR-mediated 
effects, and thus unmasks the full extent of suppression caused by A1R activation.   
 In the neocortex, A2ARs are expressed at lower levels than A1Rs. Moreover, A2ARs have 
lower affinity to adenosine (Fredholm et al. 20011, Ciruela et al. 2011), and their effect on 
synaptic transmission is less robust than that mediated via A1 receptors. This brings into 
question the role of A2A receptors in normal physiology. Of what use are two receptors for the 
same ligand which act in opposition to each other?  Evidence from other brain areas provides 
insight into a potential role for this receptor under specific circumstances.  
 Both neurons and astrocytes release adenosine and ATP into the extracellular space in 
activity-dependent manner (Pascual et al. 2005; Wall and Dale 2008; Halassa et al. 2009). This 
extracellular adenosine is suggested to set a global inhibitory tone. On the background of this 
inhibitory tone, activity of synaptic networks can be regulated both upwards and downwards. 
ATP can be co-released with transmitter from highly activated presynaptic terminals (as 
mentioned above). A high local concentration of adenosine that results from broken down ATP 
may activate A2ARs located at these synapses (Cunha 2008; Costenla et al. 2010).  These A2ARs 
can locally suppress the function of A1Rs by decreasing their affinity to adenosine, or by 
downregulating the receptor.  The result is a facilitation of transmission (and possibly an LTP) at 
the active synapses, and a more diffuse (A1R mediated) inhibition of transmission at 
surrounding synapses.  This antagonistic interaction between A2A and A1 receptors has been 
proposed to increase signal salience and mediate heterosynaptic depression (Cunha 2008, 
Pascual et al. 2005).  The previously mentioned interaction between A1 and A2A receptors at 
glutamatergic synapses in the striatum, where A1Rs and A2ARs can form heteromers on the 
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membrane surface, also suggests a role for the A2AR as a ‘concentration-dependent switch.’  At 
low concentrations, adenosine preferentially occupies A1Rs, inhibiting transmission, while high 
concentrations can activate A2ARs which then ‘switch off’ A1 activation (by decreasing the 
receptor’s affinity) and facilitate transmission (Ciruela et al. 2006, Ciruela et al. 2011; Ferré et al. 
20071,2).  This indicates possible functional relevance of two adenosine receptors with opposing 
effects.  These two examples provide some indication of how sparse A2ARs could be relevant, 
but exactly how, and under what circumstances, these two receptors interact in the neocortex 
(as well as the implications of such an interaction) remain to be elucidated. 
 
 Conclusion 
 The data presented here are generally consistent with the known possibilities of 
adenosine’s actions.  This work, however, stresses region and cell-type specificity of adenosine 
effects in the neocortex and beyond.  The presence of both pre and postsynaptic effects, and a 
role for A2ARs constitutes a characterization of layer 2/3 syanapses which is different from other 
known neocortical synapses.  A clearer picture of adenosine within the neocortex thus emerges, 
with recognition of heterogenous actions across layers.  The accumulation of information about 
the mechanisms of adenosine action at neocortical synapses provides the foundation on which 
physiological events in the neocortex can be understood.  It is known, for example, that 
adenosine mediates slow wave activity.  These cortical oscillations are shaped and permitted by 
adenosine modulation.  The postsynaptic effects discovered in layer 2/3 neurons (which mediate 
intracortical communication) can have powerful implications for the excitability of these 
neurons and subsequently cortical network activity.  In addition, the presence of functional 
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A2ARs coexisting with A1Rs opens the possibility that adenosine can fulfill a role of increasing 
signal salience or mediating plasticity in the neocortex (through the circumstances outlined 
above).  Whereas the significance of adenosine in the neocortex is well recognized, most work 
has been done on a broader physiological behavioral level.  How adenosine’s actions on a 
synaptic level permit these broader actions has remained much less studied.  The present work 
provides this characterization and elucidates the basis of action for adenosine in the neocortex.  
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